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Objective. To estimate risk of dementia in association with exposure to air pollutants. 
Methods. Six databases were searched. Cohort studies that reported the hazard ratio (HR) of 
dementia in association with exposure to air pollutants in adults > 40y were included. For all 
meta-analyses, the random-effects model was used.  
Results. A total of 16 and 13 studies were included in the systematic review and the meta-
analysis, respectively. Risk of dementia increased by 4% per 1μg/m3 increase in fine particulate 
matter level (HR, 1.04; 95%CI, [1.02, 1.06]), which was statistically significant. The risk of 
dementia increased by 3% per 10μg/m3 increase in nitrogen oxides level (HR, 1.03; 95%CI, 
[0.98, 1.08]), and by 3% per 10μg/m3 increase in nitrogen dioxide level (HR, 1.03; 95%CI, 
[1.00, 1.07]); however, the associations were not statistically significant 
Conclusion. This meta-analysis indicates a significant association between exposure to fine 
particulate matter and incidence of dementia.  
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Summary for Lay Audience 
Objective. To estimate risk of dementia in association with exposure to air pollutants. 
Methods. Six databases were searched for long-term studies. Those reported the risk of 
dementia in association to exposure to air pollutants in adults who were older than 40 years of 
age were included, and analyses of similar studies were conducted 
Results. A total of 13 studies were included in the analyses of similar studies. The risk of 
dementia increased by 4% per 1μg/m3 increase in fine particles level, which was statistically 
significant. The risk of dementia increased by 3% per 10μg/m3 increase in nitrogen oxides 
level, and by 3% per 10μg/m3 increase in nitrogen dioxide level; however, the associations 
were not statistically significant 
Conclusion. This analysis of similar studies indicates a significant association between 





I recognize and extend my deepest gratitude to my supervisors, Professor Vladimir Hachinski 
and Dr. Janet Martin. Their academic support of me over the last two years puts them in a 
special category of true mentors, impacting not only my research but also my life. Without 
their much appreciated help, this project would not have been realized. 
I thank Dr. Reza Azarpazhooh for his support and help during my graduate studies; his 
contributions to this work are greatly appreciated. 
I also extend my sincere gratitude to Dr. Marnin Heisel for his scientific and emotional support 
over the last five years. His generous help and compassionate yet professional conduct 
convinced me that the world is not devoid of kind people.   
Finally, I acknowledge the loving support of my wife, Nargess Ghazaleh, and that of my son, 
Bardiya. They kept me going. This work would not have been possible without their emotional 















Table of Contents 
Abstract ............................................................................................................................... ii 
Summary for Lay Audience ............................................................................................... iii 
Acknowledgments.............................................................................................................. iv 
Dedication ........................................................................................................................... v 
Table of Contents ............................................................................................................... vi 
List of Tables ..................................................................................................................... ix 
List of Figures .................................................................................................................... xi 
List of Appendices ........................................................................................................... xiii 
Chapter 1 ............................................................................................................................. 1 
1 Introduction .................................................................................................................... 1 
1.1 Dementia ................................................................................................................. 1 
1.2 Air pollution ............................................................................................................ 2 
1.2.1 Particulate Matter ........................................................................................ 4 
1.2.2 Nitrogen oxides ......................................................................................... 14 
1.2.3 Ozone ........................................................................................................ 20 
1.2.4 Meta-analysis on the Association of Air Pollution and Incidence of 
Dementia ................................................................................................... 23 
1.3 Objectives ............................................................................................................. 24 
Chapter 2 ........................................................................................................................... 26 
2 Materials and Methods ................................................................................................. 26 
2.1 PECO .................................................................................................................... 26 
2.2 Searching Databases and Data Extraction ............................................................ 26 
2.2.1 Information sources .................................................................................. 26 
2.2.2 Search Strategy ......................................................................................... 27 




2.2.4 Data Collection Process ............................................................................ 28 
2.2.5 Data items ................................................................................................. 29 
2.3 Risk of Bias in Individual Studies ........................................................................ 29 
2.4 Statistical Analysis ................................................................................................ 30 
2.4.1 Summary Measures ................................................................................... 30 
2.4.2 Converting Units of Measurement and Making the Estimates Comparable 
Across Studies ........................................................................................... 30 
2.4.3 Meta-analysis and Subgroup Analysis ...................................................... 32 
2.4.4 Assessing Heterogeneity Across Studies .................................................. 33 
2.4.5 Risk of bias across studies ........................................................................ 34 
2.4.6 Additional Analyses .................................................................................. 34 
Chapter 3 ........................................................................................................................... 35 
3 Results .......................................................................................................................... 35 
3.1 Study selection ...................................................................................................... 35 
3.2 Study Characteristics ............................................................................................ 36 
3.2.1 Population ................................................................................................. 37 
3.2.2 Exposure ................................................................................................... 46 
3.2.3 Controls ..................................................................................................... 46 
3.2.4 Outcome .................................................................................................... 52 
3.3 Risk of Bias Within Studies .................................................................................. 55 
3.4 Results of Individual Studies ................................................................................ 57 
3.5 Synthesis of Results .............................................................................................. 62 
3.5.1 Particulate Matter with Diameter < 2.5𝛍 .................................................. 62 
3.5.2 Nitrogen Oxides ........................................................................................ 65 
3.5.3 Nitrogen Dioxide ...................................................................................... 68 




3.6 Heterogeneity Across Included Studies ................................................................ 71 
3.7 Risk of Bias Across Studies .................................................................................. 72 
3.8 Sensitivity Analyses .............................................................................................. 75 
3.8.1 Particulate Matter with Diameter < 2.5𝛍 .................................................. 75 
3.8.2 Nitrogen Oxides ........................................................................................ 77 
3.8.3 Nitrogen Dioxide ...................................................................................... 78 
3.8.4 Ozone ........................................................................................................ 79 
3.9 Other Analyses ...................................................................................................... 80 
Chapter 4 ........................................................................................................................... 82 
4 Discussion .................................................................................................................... 82 
References ......................................................................................................................... 91 
Appendices ........................................................................................................................ 99 




List of Tables 
Table 1. Conversion of the Units of Measurement for Studied Air Pollutants ....................... 31 
Table 2.Information on Included Studies a ............................................................................. 39 
Table 3. Information on Included Studies a ............................................................................ 42 
Table 4. Information on Evaluated Pollutant, Exposure Measurement, and Exposure Period a
................................................................................................................................................. 48 
Table 5. The Population Included in Each Study and the Number of Incidence Cases a ....... 54 
Table 6. The Assessment of the Risk of Bias Using Tool to Assess Risk of Bias in Cohort 
Studies a ................................................................................................................................... 56 
Table 7. Hazard Ratio and 95% Confidence Interval of Dementia and Its Subtypes Reported 
per Increment of PM2.5 in the Included Studies a .................................................................. 58 
Table 8. Hazard Ratio and 95% Confidence Interval of Dementia and Its Subtypes Reported 
per Increment of NOx in the Included Studies 
a ...................................................................... 59 
Table 9. Hazard Ratio and 95% Confidence Interval of Dementia and its Subtypes Reported 
per Increments of NO2 in the Included Studies 
a .................................................................... 60 
Table 10. Hazard Ratio and 95% Confidence Interval of Dementia and its Subtypes Reported 
per Increment of O3 in the Included Studies 
a ......................................................................... 61 
Table 11. Egger’s Test for small-study effect ......................................................................... 75 
Table 12. The Results of the Sensitivity Analysis (Leave-One-Out Analysis) for the 
Association Between Exposure to PM2.5 and Incidence of Dementia 
a .................................. 77 
Table 13. The Results of the Sensitivity Analysis (Leave-One-Out Analysis) for the 
Association Between Exposure to NOX and Incidence of Dementia 
a ................................... 78 
Table 14. The Results of the Sensitivity Analysis (Leave-One-Out Analysis) for the 
Association Between Exposure to NO2 and Incidence of Dementia 




Table 15. The Results of the Sensitivity Analysis (Leave-One-Out Analysis) for the 
Association Between Exposure to O3 and Incidence of Dementia 
a ....................................... 80 





List of Figures 
Figure 1. PRISMA Flow Chart of Review Process and Screening Papers ............................. 36 
Figure 2. Subgroup analysis of hazard ratio per 1μg/m3 increase in PM2.5 level for all the 
studies that reported on the association of PM2.5 with incidence of any type of dementia and 
the incidence of the first-time hospitalization with dementia ................................................. 63 
Figure 3. Subgroup analysis of hazard ratio per 1μg/m3 increase in PM2.5 for the studies that 
reported on the association of PM2.5 with Alzheimer’s disease, vascular dementia, and non-
Alzheimer dementia ................................................................................................................ 64 
Figure 4. Subgroup analysis of hazard ratio per 1μg/m3 increase in PM2.5 for the studies from 
different continents that reported on the association of PM2.5 with any type of dementia ..... 65 
Figure 5. Pooled hazard ratio per 10 μg/m3 increase in NOX for the studies that reported on 
the association of NOX with dementia .................................................................................... 67 
Figure 6. Pooled hazard ratio per 10μg/m3 increase in NOX for the studies that reported on 
the association of NOX with dementia when study on the first-time hospitalization was 
introduced as a subgroup ........................................................................................................ 67 
Figure 7. Subgroup analysis of hazard ratio per 10 μg/m3 increase in NO2 for the studies that 
reported on the association of NO2 with incidence of dementia, first-time hospitalization with 
dementia, and non-Alzheimer dementia ................................................................................. 69 
Figure 8. Subgroup analysis of hazard ratio per 10 μg/m3 increase in O3 for the studies that 
reported on the association of O3 with incidence of dementia, first-time hospitalization with 
dementia, and Alzheimer’s disease ......................................................................................... 70 
Figure 9. Subgroup analysis of hazard ratio per 10 μg/m3 increase in O3 for the studies that 
reported on the association of O3 with incidence of Alzheimer’s disease and vascular 
dementia .................................................................................................................................. 71 
Figure 10. Funnel plot to evaluate publication bias in studies reporting on association of 




Figure 11. Funnel plot to evaluate publication bias in studies reporting on association of 
exposure to NOX with incidence of dementia and its subtypes .............................................. 73 
Figure 12. Funnel plot to evaluate publication bias in studies reporting on association of 
exposure to NO2 with incidence of dementia and its subtypes ............................................... 73 
Figure 13. Funnel plot to evaluate publication bias in studies reporting on association of 






List of Appendices 





Chapter 1  
1 Introduction 
1.1 Dementia 
Neurological disorders account for 10% of the global burden of disease and are the leading 
cause of disability-adjusted life years (DALYs). About 10% of DALYs from neurological 
disorders are due to dementia. While the trend of prevalence and incidence of dementia is 
stable or declining in high-income countries, low-income and middle-income countries are 
expecting a rise in the burden of dementia (1). The annual cost of dementia in the United 
States was estimated to be around 157 to 215 billion dollars (2). While the Canadian 
population is considerably smaller than the United States, the burden of dementia was 
reported to be 15 billion dollars in 2008, and is expected to reach 153 billion dollars in 
2038 (3, 4). 
Dementia is categorized as Alzheimer’s disease (AD) and non-Alzheimer dementia (NAD) 
with AD being the most commonly diagnosed type of dementia. An important proportion 
of NAD is vascular dementia (VaD). The subtypes of dementia including AD are diagnosed 
clinically; however, neuropathological examination of the brain of 1,161 deceased 
individuals with dementia demonstrated that 41% of AD cases could be attributed to AD 
pathology alone and pathological features related to other types of dementia could be seen 
in those diagnosed with dementia. In addition, over two-thirds of cases of AD could be 
attributed to other neuropathologies that were common for the age of individuals (5). These 
findings infer that relying on the clinical diagnosis of dementia subtypes might be 
misleading, and it is better to evaluate all of them under the umbrella of dementia.  
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Numerous genetic, behavioural, and environmental factors are associated with dementia. 
The important risk factors for dementia are age, female sex, traumatic brain injury, current 
smoking, low educational level, and pre-existing metabolic disorders or cardiovascular 
diseases (CVD) (6, 7). Age is the most important risk factor for developing dementia and 
the prevalence increases from 2% to 3% at age 65 to more than 30% at age 90 or older (8-
10). Along with the increasing population worldwide and improvement in public health, 
the elderly will constitute a large proportion of the population. It means that an increase in 
chronic and non-communicable diseases of the elderly, including dementia, should be 
expected. It is estimated that the number of people with dementia will rise from 44 million 
individuals in 2013 to 135 million in 2050 (11). Due to such an important effect on health 
and economy, the World Health Organization announced dementia as a public health 
priority (12). Therefore, understanding and preventing the causes of dementia would be 
beneficial to both healthcare systems and governments. 
One of the environmental factors that is hypothesized to be associated with dementia is air 
pollution. Air pollution has become a global concern during the recent decades and its 
association with numerous medical conditions has been reported. During the last decade, 
the association of air pollutants with cognitive decline and dementia has been examined 
and there was a discrepancy among the reported associations. 
1.2 Air pollution 
Air pollution has been associated with adverse health outcomes (13). There is a large body 
of evidence that associates air pollution to CVD (14), respiratory diseases (15-17), 
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psychiatric disorders such as depression and suicide (17), and neurological disorders 
including decline in cognitive function and dementia (18, 19).  
The pollutants can be of natural sources or human-activity-related sources. Natural sources 
include volcanic activities, wildfire, and dust, and are difficult to control. Sources related 
to human-activity are mainly from traffic, home cooking and heating, industrial 
combustion of fossil fuels, mining, and agriculture. Human-activity-related pollutants can 
be reduced with appropriate intervention. Some of the most important air pollutants are 
particulate matter (PM), especially PM of diameter less than 2.5μm (PM2.5), nitrogen 
oxides (NOX) including nitrogen dioxide (NO2) and nitrogen monoxide (NO), and ozone 
(O3). Some strategies to decrease traffic-related air pollution have shown beneficial effects 
on health (20). Therefore, the level of air pollutants should be kept low to prevent 
detrimental health outcomes. The World Health Organization (WHO) air quality guideline 
indicated that the annual and daily mean levels of PM2.5 should not exceed 10μg/m
3 and 
25μg/m3, respectively. The guideline levels for the annual and daily mean levels of NO2 
are 40μg/m3 and 200μg/m3, respectively. The recommended threshold for mean levels of 
O3 is 100μg/m
3/8 hour. Nonetheless, according to “Ambient (outdoor) air quality and 
health” report by WHO in 2016, about 91% of the world population were living in regions 
where the level of pollutants exceeded the WHO air quality guidelines. This report also 
estimated that about 4.2 million premature deaths worldwide were due to exposure to air 
pollution. Most of the deaths occurred in low-income and middle-income countries (21).  
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1.2.1 Particulate Matter 
Particulate matter (PM) is a collective name for a group of particles with different sizes 
and various composition that can be liquid or solid. Particulate matter might be of natural 
or human-activity-related sources. The primary PM is produced directly from natural or 
human-activity-related sources. Secondary PM is a complex combination of different 
pollutants due to photochemical reactions in the atmosphere (22).  
Particulate matter is produced in various sizes. The United States Environmental Protection 
Agency (EPA) has categorized PM according to the diameter of the particles, ranging from 
ultrafine, fine, and coarse PM.  
Ultrafine PM has a dimeter of < 100nm and therefore, it is called PM0.1. The main 
constituents of ultrafine PM are organic matters with inorganic ions and metals being its 
minor constituents. The fine PM (PM2.5) has a diameter of < 2.5μm and its main 
constituents are inorganic ions, with metals and organic matter being its minor constituents. 
Coarse PM (PM10) has a diameter between 2.5μm and 10μm with inorganic ions and metals 
being its main constituents (23). The importance of this categorization is that each particle 
might have a different fate and unique effect on the human body.  
While PM10 is mainly trapped in the upper respiratory tract, PM0.1 and PM2.5 not only 
deposits in the lungs, but also enters the circulation and is taken up into cells and may cross 
the brain-blood barrier (24). In addition, PM0.1 can directly enter the brain through olfactory 
nerve endings in the nose (25). The surface of PM0.1 and PM2.5 can also carry other 
hazardous chemicals and metals (26), and their entrance into the blood stream and brain 
may lead to cell damage. The entrance of PM in the brain cells can initiate inflammation, 
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neurotoxicity, neuronal damage, and cell loss (27). In addition, there is an association 
between exposure to PM and cardiovascular morbidity and mortality (28), which is a risk 
factor for dementia and can lead to cognitive impairment and contribute to the development 
of dementia and AD (29). 
While the negative effect of pollution on cognition has been studied in children whose 
mothers were exposed to air pollution during pregnancy, the results have been discrepant. 
One component of PM is the polycyclic aromatic hydrocarbons (PAHs) that is shown to 
be associated with decreased verbal and overall IQ in 5-year-old children born to African-
American and Dominican mothers in New York city who were exposed to PAHs during 
pregnancy (30). On the other hand, a meta-analysis of six European studies on the 
association between prenatal exposure to air pollutants and psychomotor development did 
not show any association with PM10 or PM2.5 (31). Harris et al. studied the association of 
prenatal exposure to traffic-related air pollution, specifically PM2.5, in 1109 mother-child 
pairs in Eastern Massachusetts and reported a limited association between exposure to 
PM2.5 and childhood cognitive decline (32). This heterogeneity in suggested associations 
might be due to different levels of exposure to pollutants and potential unknown 
interactions between other pollutants affecting overall toxicity. In addition, PM is a mixture 
of various chemical elements and its composition might differ from region to region and 
from time to time according to other environmental factors.  
The negative effect of exposure to air pollution is not limited to the prenatal period. 
Childhood exposure to air pollutants is also associated with cognitive decline. In a pilot 
study in Mexico City, Calderón-Garcidueñas et al. evaluated 134 consecutive autopsies of 
subjects with the mean age of 20 (range, 11mo to 30y) and reported progressive 
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development of AD in 99.25% of the autopsies. They also reported cognitive impairment 
in 66% of healthy individuals ≤ 30 years old who were exposed to more than standard 
levels of PM2.5 and O3 during their lifetime (33). 
Numerous studies have shown the association between air pollution and cognitive decline 
in the elderly population. In a study of elderly women from the SALIA cohort (duration, 
22 y) in Germany, Schikawski et al. reported a significant decrease in the semantic memory 
and visuo-construction subsets of cognitive function with increases in NOx and PM. In 
addition, they reported a significant association of decline in cognitive function in the 
carriers of APOE ϵ4 allele (34). Gatto et al. investigated the association of air pollution 
with different domains of cognition in adults (mean age, 60.5 y) in Los Angeles and 
reported lower verbal learning in those exposed to PM2.5 and lower logical memory in those 
exposed to NO2 (35).  
Alishire and Clarke studied the cognitive function of 780 Hispanic participants in the 
American Changing Lives Study and evaluated the association of the cognitive errors with 
exposure to PM2.5 using the Short Portable Mental Status Questionnaire (SPMSQ). Their 
results showed that in comparison to exposure to the lower levels of PM2.5, exposure to 
higher levels of PM2.5 was associated with 1.5 times higher error rates in working memory 
and orientation domains of cognitive function (36). 
Another study of 19,409 women from Nurses’ Health Study Cognitive Cohort in the United 
States evaluated the association of PM with global cognition. This study indicated a decline 
in global cognition among those who were exposed to higher levels of PM2.5 in comparison 
to those exposed to lower levels. In addition, there was a linear association between 
7 
 
increase in PM2.5 levels and decline in global cognition in a two-year evaluation interval. 
They indicated that higher levels of PM was associated with faster cognition decline (37). 
Lin et al. studied the association of PM2.5 with overall and domain-specific disability 
according to the 12-item version of the World Health Organization Disability Assessment 
Schedule (WHODAS 2.0) among adults of six low-income and middle-income countries. 
Evaluation of the data from 45,625 participants of the Study on global AGEing and adult 
health (SAGE) from these countries showed an increase over baseline of 0.72 (95%CI, 
[0.22, 1.22]) in overall WHODAS score (maximum score: 48) and 0.10 (95%CI, [0.02, 
0.18]) increase in cognitive domain per 10μg/m3 increase in PM2.5 level. In addition, they 
indicated that women and older adults are more at risk of being affected by ambient PM 
(38). 
Although cognitive decline might be the early manifestation of dementia, not everyone 
with cognitive decline will progress to dementia. Therefore, the risk of cognitive decline 
does not necessarily indicate the risk of dementia and longitudinal studies are required to 
evaluate the risk of dementia in association with air pollutants. In addition, similar as for 
other chronic conditions, time-to-event analysis and reporting the hazard ratio (HR) in 
cohort studies seems to be the appropriate measure of risk of dementia due to chronic 
exposure to high levels of PM. 
The association between PM and dementia has been studied in several epidemiological 
cohorts. In a population-based cohort study in Taiwan, Jung et al. examined the association 
between PM2.5 and AD by using the data from 95,690 individual from the longitudinal 
health insurance database (LHID2000). Their study reported a 3% increase in the hazard 
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of developing dementia per interquartile range (IQR) of PM2.5 (13.21μg/m
3); however, the 
association was not statistically significant (HR, 1.03; 95%CI, [0.95, 1.11]) (39).  
In 2017, Cacciottolo et al. evaluated the association between exposure to PM2.5 and 
cognitive impairment in 3,647 women from The Women’s Health Initiative Memory Study 
(WHIMS) in the United States. Their study showed higher risk of dementia in those 
exposed to higher levels of PM2.5 (> 12μg/m
3) in comparison to those exposed to lower 
levels (HR, 1.92; 95%CI, [1.32, 2.80]). Moreover, they showed that the presence of APOE 
ε4 is associated with a higher HR of developing dementia (ε3/3: HR, 1.68; 95%CI, [0.97, 
2.92]; ε3/4: HR, 1.91; 95%CI, [1.17, 3.14[; and ε4/4: HR, 3.95; 95%CI, [1.18,13.19]) (40).  
Oudin et al. evaluated the association between PM2.5 and dementia in 1,806 individuals 
from the Betula project in Sweden. They evaluated the HR for dementia (AD and VaD) for 
exposure to PM2.5 due to residential wood burning as well as traffic exhaust. Their results 
indicated a significant association between PM2.5 from residential wood burning and 
dementia for the group with high exposure levels compared to the group with lower 
exposure levels (HR, 1.74; 95%CI, [1.10, 2.75]). In addition, the association between PM2.5 
from traffic exhaust and dementia was statistically significant in those exposed to higher 
levels of PM2.5 compared to those exposed to lower levels (HR, 1.41 95%CI, [0.97, 2.23]) 
(41). 
In a study by Carey et al., 131,869 residents of the great London, the United Kingdom, 
who were registered with a general practice were evaluated for the association of several 
air pollutants including traffic-related PM2.5 with dementia. The study indicated an 8% 
increase in HR of dementia (HR, 1.08; 95%CI, [1.01 to 1.16]), 13% increase in HR of AD 
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(HR, 1.13; 95%CI, [1.02 to 1.26]), an 8% increase in HR of VaD (HR, 1.08; 95%CI, [0.95 
to 1.23]), and an 8% increase in HR of non-specific dementia (HR, 1.08; 95%CI, [0.97 to 
1.19]) per interquartile change in the traffic-related PM2.5 (0.58μg/m
3). These results 
indicated a stronger association between PM2.5 and AD than any other subtype of dementia. 
In addition, the study did not report any association between night-time noise levels (HR, 
1.01; 95%CI, [0.98, 1.03]; per IQR change of night-time noise level [+2.68 dB]) or distance 
to major roads (HR, 1.00; 95%CI, [0.95, 1.05]; per IQR change in distance from major 
roads [-310m]) and dementia when the regression model was adjusted for other pollutants 
(PM2.5 and NO2) (42). This finding might indicate that the main causal pathway to dementia 
is affected by air pollutants, and proximity to roads is a factor that increases the chance of 
exposure to traffic pollution.  
Another study from Sweden, evaluated the exposure to PM2.5 and risk of dementia in 2,927 
individuals in the Kungsholmen district of Stockholm using the data from Swedish 
National Study on Aging and Care in Kungsholmen (SNAC-K). They reported a 
statistically significant risk of developing dementia during the five-year period preceding 
the exposure to PM2.5 (HR, 1.54; 95%CI, [1.33, 1.78]; per IQR difference of PM2.5 [0.88 
μg/m3]). There was also a statistically significant association between exposure to PM2.5 
and incidence of VaD (HR, 1.54; 95%CI, [1.33, 1.78]; per IQR difference of PM2.5 [0.88 
μg/m3]). This study aimed to evaluate the mediatory role of CVD in development of 
dementia due to air pollution, and reported stroke as the most important intermediate 
condition that might mediate the effect of air pollution in developing dementia (43). 
In a case-control study to evaluate the association of PM10 with AD and VaD, Wu et al. 
recruited 249 patients with AD, 125 patients with VaD, and 497 controls from three 
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teaching hospitals in northern Taiwan. Their study showed approximately four times higher 
odds of AD in those exposed to the highest tertile (> 49.23 μg/m3) compared to the lowest 
tertile (< 44.95 μg /m3) of PM10 level (OR, 4.17; 95%CI, [2.31, 7.54]). Moreover, the odds 
of VaD in the highest tertile was almost 3.5 times of the odds in the lowest tertile (OR, 
3.61; 95%CI, [1.67, 7.81]) (44).  
In a nested case-control study among the beneficiaries of Taiwan’s National Health 
Insurance program (Taiwan’s National Health Insurance Research Database [NHIRD]), Li 
et al. could not find any association between VaD and exposure to PM10 five years before 
developing dementia (OR, 0.99; 95%CI, [0.98, 1.00]; per 10μg/m3 increase in PM10) (45). 
These results are expected because PM10 is usually caught in macrophages and cells of 
upper and lower respiratory tract and might not be the main culprit in developing dementia. 
1.2.1.1 Studies in Canada 
The association between air pollution and dementia was studied in three provinces of 
Canada, namely, Ontario, British Columbia, and Quebec.  
The first population-based study in Canada was conducted in 2017 by Chen et al. who used 
the data from Ontario Population Health and Environment Cohort (ONPHEC) to evaluate 
the association of air pollution with incidence of dementia among the Canadian-born 
residents of Ontario who were registered in the provincial healthcare plan (OHIP). Of 
approximately 2.06 million individuals followed from 2001 to 2013, there was a 3% 
increase in HR of dementia (HR, 1.03; 95%CI, [1.02, 1.04]; per IQR difference of PM2.5 
[4.8μg/m3]). In addition, they attributed 2.4% (95%CI, [1.8%, 3.0%]) to PM2.5 alone. When 
including cases due to NO2 exposure, 6.1% (95%CI, [4.8%, 7.5%]) of dementia incidence 
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could be attributed to air pollution (46). This study suggests the potential importance of 
addressing air pollution in preventing a considerable fraction of dementia. 
In a population-based retrospective cohort study, Ilango et al. evaluated the mediatory role 
of CVD in the association between incidence of dementia and air pollution in residents of 
Ontario, Canada, from 2001 to 2013. The study population included 34,391 Canadian-born 
Ontario residents who had resided in this province for at least five years. In order to assess 
the mediating role of CVD, the investigator considered a three-year exposure period 
followed by a five-year lag. During the five-year lag after exposure period, CVD could 
occur, but if the patients developed dementia, they would be excluded from the analysis. 
Their results indicated around 30% increase in HR of dementia per 10μg/m3 increase in 
PM2.5 levels; however, the result was not statistically significant (HR, 1.29; 95%CI, [0.99, 
1.64]). On mediation analysis, almost 21% (on multiplicative model) and 4% (on additive 
model) of the association of PM2.5 with the incidence of dementia was attributed to causal 
pathways related to CVD (47). 
In British Columbia, Yuchi et al. evaluated the association between air pollutants and 
developing NAD and AD by evaluating 633,949 individuals from the ministry of health 
database, using a nested-case-control design to evaluate the association between air 
pollution and AD. Their study indicated a nonsignificant association between PM2.5 and 
NAD (HR, 1.02; 95%CI, [0.98, 1.05]; per IQR difference of PM2.5 [1.54μg/m
3]). In 
addition, they did not find association between noise and developing NAD, but reported an 
attenuating effect of greenness on the association between exposure to PM2.5 and NAD. 
The analysis of nested-case control data indicated no statistically significant association 
12 
 
between AD and exposure to PM2.5 (OR, 0.90; 95%CI, [0.76, 1.07]; per IQR increase of 
1.54 μg/m3] (48). 
In a retrospective population-based cohort study, Smargiassi et al. investigated the 
association of ambient air pollution with the risk of developing dementia in an open cohort 
of 1,807,133 individuals who had resided in Quebec for the previous four years. Their 
results showed a 1.5% increase in HR of dementia per 3.90 μg/m3 (IQR) increase in PM2.5 
level (HR, 1.02; 95%CI, [1.01, 1.03]). The increase in the HR of dementia was around 5% 
per 2.10μg/m3 (IQR) increase in PM2.5 level in the island of Montreal (HR, 1.05; 95%CI, 
[1.03, 1.07]). Distance from major roads was negatively associated with the incidence of 
dementia (HR, 0.95; 95%CI, [0.94–0.96]; per 150m distance from major roads[IQR]) (49). 
1.2.1.2 First-Time Hospitalization With Dementia 
In addition to association with total incidence of dementia, the association of air pollution 
with incidence of the first-time admission to hospital with the diagnosis of dementia has 
been evaluated in a few studies.  
The association between long-term exposure to PM2.5 and hospitalization for neurological 
disorders including dementia was evaluated in 50 cities of the northern United States. In 
this population-based cohort study, Kioumourtzoglou et al. evaluated 9.8 million fee-for-
service Medicare enrollees who had exposure to PM2.5 during 1999 through 2010. They 
excluded cases that developed dementia during the first two years of enrollment and 
included the remaining 7.9 million enrollees for their time-to-event analysis. The study 
indicated 15% (HR, 1.15; 95%CI, [1.10, 1.19]) and 7% (HR, 1.07; 95%CI, [1.04, 1.11]) 
increase in the HR of the first-time hospitalization with dementia and AD per 1μg/m3 
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increase in PM2.5 levels, respectively, with similar rates for men and women. In addition, 
they found 8% increase in HR of first-time hospitalization with Parkinson’s disease per 
1μg/m3 increase in PM2.5 levels (HR, 1.08; 95%CI, [1.04, 1.12]), potentially relating 
negative association of air pollution with the central nervous system diseases (50). 
In a population-based cohort study in Rome, Italy, Cerza et al. evaluated the association 
between air pollution and first-time hospitalization with dementia. They evaluated 350,884 
residents of Rome who had completed the population census in 2001 and followed them 
until 2013. The study reported no statistically significant association between exposure to 
PM2.5 (HR, 0.99; 95%CI, [0.96, 1.02]; per 5μg/m
3 increase]) as well as PM10 (HR, 1.00; 
95%CI, [0.98, 1.03]; per 10μg/m3 increase]) with the first-time hospitalization with 
dementia. Moreover, such an association was not statistically significant for AD and senile 
dementia. On the other hand, first-time hospitalization with VaD was significantly 
associated with increase in levels of PM2.5 (HR, 1.07; 95%CI, [1.01, 1.12]; per 10μg/m
3 
increase]) and PM10 (HR, 1.06; 95%CI, [1.02, 1.10]; per 10μg/m
3 increase]). In addition, 
the association of dementia and its subtypes with distance from high-traffic road was only 
significant for AD (51). 
Lee et al. evaluated the association between exposure to PM2.5 and hospitalization with 
dementia in seven southern states of the United States. In this population-based study, they 
evaluated 13.3 million Medicare beneficiaries and followed the participants for 13 years. 
The study results indicated that for each 1μg/m3 increase in PM2.5, there was a 5% increase 
in HR of the first-time admission with dementia (HR, 1.049; 95%CI, [1.048, 1.051]), 6% 
increase in HR of the first-time admission with AD (HR, 1.60; 95%CI, [1.057, 1.062]), and 
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9% increase in HR of the first-time admission with VaD (HR, 1.086; 95%CI, [1.082, 
1.090]) (52). 
1.2.2 Nitrogen oxides 
Nitrogen oxide species (NOX) are composed of nitrogen dioxide (NO2) and nitrogen 
monoxide (NO). This combination makes it hard to evaluate the association of NOx with 
dementia because the combination of NO2 and NO varies from region to region. Nitrogen 
dioxide is a traffic-related air pollutant that is generated primarily from vehicles and can 
cause detrimental effects on health. The levels of NO2 have been increasing worldwide. 
One study showed that the levels of NO2 in 1996 had increased by 2.7 times in 2012 (53).  
Animal studies have shown that prenatal exposure to NO2 is associated with problems in 
neuromuscular coordination and functional deficits in mice (54). Some studies on pregnant 
women who were exposed to air pollutants reported that the effect of NOX on brain might 
be due to oxidative stress (55, 56). Evidence also suggests that NO2 disrupts the blood-
brain barrier and leads to neural inflammation in children (57, 58). These studies indicate 
that the detrimental effects of NOX can start with intrauterine exposure to nitrogen oxides. 
It has been proposed that intrauterine exposure of human fetus to NOX is associated with 
poor cognitive outcomes in early childhood.  
In a study on 1,889 children whose mother had been exposed to NO2 in the first trimester 
of pregnancy, NO2 had inverse association with mental development although the 
association was not significant (β, -0.95; 95%CI, [-3.90, 1.89]) (59). Another study on 
9,426 children of one to six years old from six European birth cohorts, namely, 
GENERATION R (The Netherlands), DUISBURG (Ger many), EDEN (France), GASPII 
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(Italy), RHEA (Greece), and INMA (Spain), showed that prenatal exposure to NO2 is 
associated with decreased global psychomotor development (β, -0.65; 95%CI, [-1.25, -
0.11]). Such an association was not seen with general cognition or language development. 
In addition, significant association was not found between cognitive decline and other air 
pollutants including, NOx, PM2.5, and PM10 (31). In a population-based study in Spain, 438 
mother-child pairs were recruited and children were evaluated around 15 months of age by 
the Bayley Scales of Infant Development. The results indicated that for 1μg/m3 increase in 
exposures level of NO2 during pregnancy, child’s mental scale score of decreases by 0.29 
points (90%CI, [-0.47, -0.11]); however, such an association was not statistically 
significant for motor scale score (β, -0.14, 90%CI, [-0.34, 0.06]) (60). 
Early life exposure to NO2 is reported to have negative association with child development. 
In a cohort study in Malaga Province, Spain, 210 children were followed for a year and 
their motor and cognitive development was evaluated at age five with McCarthy Scales of 
Children's Abilities (MSCA). Children with higher level of exposure (> 24.75μg/m3) 
showed a decrease in domains of cognitive function including general cognition score (β, 
-4.19; 95%CI, [-14.02, 5.64]), quantitative (β, 6.71; 95%CI, [-17.91, 4.49]), working 
memory (β, -7.37; 95%CI, [-18.98, 4.24]), and gross motor (β, -8.61; 95%CI, [-18.96, 
1.74]) areas. Nonetheless, none of these changes were statistically significant (61). 
In a study in Amsterdam, Netherlands, 553 school-age children of nine to 11 years old were 
evaluated for the association of exposure to NO2 and transportation noise with cognitive 
performance of children at school. The results indicated significant decline in memory span 
length at school (χ2, 6.8; df, 1; p-value = 0.01). When the outcome was adjusted for 
transportation and aircraft noise, the association remained statistically significant (χ2, 5.9; 
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df, 1; p-value = 0.015), indicating the association of exposure to NO2 with memory span 
length was independent of surrounding noise (62). 
The negative effect of NO2 on cognition continues during adulthood and those exposed to 
air pollution later in life are not necessarily spared. In a cross-sectional study in the United 
States, 1,496 healthy men and postmenopausal women (mean age, 60.5 y) were evaluated 
for the association of air pollutants including NO2 with cognitive function. There was no 
statistically significant difference between those exposed to higher levels of NO2 (> 20ppb) 
and those exposed to lower levels of NO2 (< 10ppb) in global function or any of the six 
measured cognitive domains (executive function, verbal learning, logical memory, visual 
memory, semantic memory, and visual processing). However, there was a decrease in 
logical memory (β, -0.62; 95%CI, [-1.35, 0.11]), global function (β, -0.32; 95%CI, [-0.92, 
0.28]), visual memory (β, -0.26; 95%CI, [-0.97, 0.45]), and semantic memory (β, -0.24; 
95%CI, [-0.87, 0.39]) (35). The lack of significance in this study might be due to small 
sample size but inverse association of NO2 with domains of cognitive function raises the 
possibility of association with further decline in cognitive function and progression to 
dementia in the future. 
Several studies have investigated the association between NOX and NO2 with dementia and 
its subtypes with discrepant results. 
In a study by Chang et al. in Taiwan, data of 29,545 individuals (mean age, 61.5 y) from 
the NHIRD were evaluated for the association between exposure to NO2 and dementia 
from 2000 to 2010. Their results indicated 54% increase in HR in those exposed to the 
fourth quartile compared to those exposed to the first quartile of NO2 levels (HR, 1.54; 
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95%CI, [1.34, 1.77]). The same increase in HR ratio was seen for male (HR, 1.52; 95%CI, 
[1.23, 1.88]) and female subgroups (HR, 1.56; 95%CI, [1.29, 1.87]) indicating no 
difference in the risk of dementia between sexes regarding exposure to NO2 (63). 
In a population-based cohort study in northern Sweden, Oudin et al. used data of 1,806 
individuals from Betula project to evaluate the association between exposure to NOX and 
development of AD and VaD. They followed patients for a maximum period of 15 years 
(1995-2010) and compared the highest level of exposure (> 26μg/m3) to the lowest level 
of exposure (< 9μg/m3) and reported 38% increase in HR of AD (HR, 1.56; 95%CI, [1.29, 
1.87]) and 47% increase in HR of VaD (HR, 1.56; 95%CI, [1.29, 1.87]). However, such an 
association was not statistically significant for changes in HR per 10μg/m3 increase in level 
of NOX (AD: HR, 1.05; 95%CI, [0.97, 1.15]; and VaD: HR, 1.02; 95%CI, [0.92, 1.14]) 
(64). Using the same database, the authors later evaluated the role of APOE ϵ4 and did not 
find any evidence of modifying HR of dementia by this genotype (65). This might indicate 
that the association of NOX with cognition and dementia is through another pathway that 
does not involve APOE ϵ4. Andersson et al. used the data from the same cohort and 
indicated no association between noise and dementia (66), suggesting that the association 
of NOX with developing dementia is not modified by noise or in other words, may be due 
to air pollution itself rather than traffic-related noise.  
In a study by Carey et al. in London, United Kingdom, exposure to NO2 was associated 
with dementia, AD, and VaD; however, this association was not statistically significant for 
VaD (HR, 1.15; 95%CI, [0.96 to 1.39]; per IQR of 7.5μg/m3). Their study indicated that 
per one IQR increase in NO2 levels, HR ratio of dementia and AD increase by 16% (HR, 
1.16; 95%CI, [1.05 to 1.28]) and 23% (HR, 1.23; 95%CI, [1.07 to 1.43]), respectively. In 
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addition, adjustment for night-time noise had slight modification on the association 
between dementia and NO2 (42).  
Another study in Sweden evaluated the mediator role of CVD in the causal association 
between NOX and dementia. In this study, 2,927 individuals with mean age 71.4 years from 
Swedish National Study on Aging and Care in Kungsholmen (SNAC-K) were selected. 
The HR of dementia increased by 14% per IQR difference (8.35μg/m3) in mean exposure 
to NOX during the last preceding five years at the residential address (HR, 1.14; 95%CI, 
[1.01 to 1.29]). Although HR of dementia increased with the presence of heart failure and 
ischemic heart disease, the mediation analysis did not show any mediatory role of CVD on 
the association of NOX and dementia (OR, 1.11; 95%CI, [0.93, 1.32]) (43).  
In a case-control study using NHIRD, Li et al. evaluated the association of NO2 with VaD 
in Taiwan. Their results indicated higher odds of VaD in those exposed to higher levels of 
NO2 in comparison to the lowest levels five years before the diagnosis of VaD (OR, 2.22; 
95%CI, [1.35, 3.65]). On the other hand, there was no statistically significant association 
between NO2 levels and dementia when the incremental levels of NO2 were fitted (OR, 
1.28; 95%CI, [0.98, 1.66]; per IQR of 4.69ppb)(45).  
1.2.2.1 Studies in Canada 
In a large population-based cohort study in Ontario, Canada, data of over two million 
individuals with the mean age of 66.8 years from Ontario Population Health and 
Environment Cohort (ONPHEC) were evaluated for the association between NO2 and 
dementia. The study indicated a 10% increase in HR of dementia per IQR (4.8μg/m3) 
increase in NO2 levels (HR, 1.10; 95%CI, [1.08, 1.12]) (46). Another study in Montreal, 
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Quebec, Canada, evaluated the association of NO2 with the incidence dementia by 
evaluating 1.8 million individuals over 65 years of age. The study indicated 1.5% increase 
in incidence of dementia per IQR (13.26ppb) change in NO2 levels (HR, 1.015; 95%CI, 
[1.007, 1.023]); however, after including PM2.5 levels in the model this became statistically 
insignificant (HR, 1.005; 95%CI, [0.994, 1.017])(49). The population-based cohort study 
on the association of NOx with NAD in Vancouver, British Columbia, Canada, did not 
indicate a significant association between incidence of NAD and exposure to NO2 (HR, 
1.02; 95%CI, [0.99, 1.06]; per IQR of 9.1ppb) or NO (HR, 1.00; 95%CI, [0.96, 1.04]; per 
IQR of 12ppb). They designed a nested-case-control study within their cohort to evaluate 
the association of air pollution with AD and reported a statistically significant lower odds 
of exposure to NO2 in cases (OR, 0.84; 95%CI, [0.70, 0.99]; per IQR of 8.96) and no 
statistically significant association between NO and AD (OR, 0.91; 95%CI, [0.77, 1.11]; 
per IQR of 13.68) (48). 
1.2.2.2 First-Time Hospitalization With Dementia 
A population-based study by Cerza et al. in Rome, Italy reported on the association 
between NOX and first-time hospitalization with dementia, and found a marginal increase 
in HR of dementia per 20µg/m3 increase in levels of NOX (HR, 1.01; 95%CI, [1.00, 1.02]). 
Such an increase in the incidence of the first-time hospitalization was seen with VaD (HR, 
1.08; 95%CI, [1.06, 1.10]), but not with AD (HR, 0.96; 95%CI, [0.94, 0.98]). In addition, 
they reported a higher HR for dementia in women who were exposed to NOX (HR, 1.10; 
95%CI, [1.07, 1.12]) in comparison to men (HR, 1.06; 95%CI, [1.03, 1.09]). Regarding 
NO2 levels, there was a statistically significant increase in incidence of first-time 
hospitalization with VaD (HR, 1.08; 95%CI, [1.06, 1.10]) and not with AD (HR, 0.91; 
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95%CI, [0.89, 0.94]) per 10µg/m3 increase in levels of NO2 (51). Some part of such an 
association with air pollution might be due to comorbidities such as CVD that are both 
associated with air pollution and are at risk for VaD. 
1.2.3 Ozone 
Ozone (O3) is also an important pollutant, which is a strong oxidant. Animal and cellular 
studies have shown that inhaled O3 has neurotoxic effects (67-69) and may interfere with 
the central nervous system and contribute to dementia pathology. The association between 
exposure to ambient O3 and cognitive function decline is a recently described phenomenon, 
and therefore, few studies have reported on such an association.  
In a cross-sectional study, Chen et al. conducted a secondary analysis on Neurobehavioral 
Evaluation System-2 (NES2) data of 1,764 adults with mean age of 37.5 (SD,10.9) years 
who participated in the Third National Health and Nutrition Examination Survey in 1988–
1991. Their results showed that for every 10ppb increase in annual O3 a consistent increase 
was seen in symbol-digit substitution test (SDST; measures coding ability; β, 0.16; 95%CI, 
[0.01, 0.23]) and in serial-digit learning test points (SDLT; measures attention and short-
term memory; β, 0.56, 95%CI, [0.07, 1.05]), which was equivalent to 3.5 and 5.3 years 
age-related decline in cognitive function (70).  
Another cross-sectional study in Los Angeles, California, evaluated the association of air 
pollution with six domain-specific cognitive functions and a measure of global cognitive 
function in 1,469 middle-aged and older adults (mean age, 60.5 y). Their results indicated 
that exposure to an annual mean O3 of 49ppb was associated with decrease in scores of 
verbal learning (β, −0.20; 95%CI, [−0.63, 0.2]) and executive function (β, −0.66; 95%CI, 
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[−1.35, 0.03]); however, only the decrease in executive function seemed to be associated 
with exposure to higher levels of O3. In addition, there was no association between 
exposure to O3 and decline in global cognitive function (71). 
In a retrospective population-based cohort study on participants of the national Alzheimer’s 
Disease Center (ADC) program, the association between exposure to air pollution and 
cognitive decline was evaluated. The investigators followed 5,419 individuals for a 
maximum of 7.5 years and reported a correlation between exposure to O3 and decline in 
cognitive function as there was a significant difference in MMSE score between those 
exposed to lowest (30.4ppb to 36.7ppb) and highest levels (40.0ppb to 47.5ppb) of O3 (β, 
0.3; 95%CI, [0.1, 0.5]). The authors concluded that exposure to higher levels of O3 
accelerates cognitive decline and the presence of APOE ϵ4 accelerates such a decline (72). 
In a case-control study in Taiwan, exposure to higher levels of ozone was associated with 
almost twice higher odds of developing AD (OR, 2.0; 95%CI, [1.14, 3.50]) and VaD (OR, 
2.09; 95%CI, [1.01, 4.33]) when the highest tertile (> 21.56ppb) of exposure was compared 
to the lowest tertile (< 20.20ppb). They did not find any evidence of modifying the 
association between exposure to O3 and VaD by APOE ϵ4 (44). On the other hand, in the 
nested case-control study in Taiwan by Li et al., there was no statistically significant 
association between odds of exposure to O3 within five-years before diagnosis and 
incidence of dementia (45). 
A few cohort studies have evaluated the association between exposure to O3 and HR of 
dementia. A population-based cohort study in Taiwan on 95,690 individuals (age ≥ 65 y) 
between 2001 to 2010 demonstrated a 6% increase in HR of AD per IQR (9.36ppb) increase 
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in O3 levels over baseline (HR, 1.06; 95%CI, [1.00, 1.12]). When the change in O3 (10.91 
ppb) during follow-up period was used in the model, the HR of newly diagnosed AD was 
increased by 211% (HR, 3.12; 95%CI, [2.92, 3.33]) (39). Their results indicated that the 
increasing trend of O3 concentration over the follow-up period was more strongly 
associated with incidence of AD than simply mean annual levels of exposure. 
In a population-based cohort study in the United Kingdom, a decreasing trend in the 
incidence of dementia, AD, and VaD was seen with IQR change (+5.6μg/m3) of O3; 
however, the decrease in HR was statistically significant for dementia (HR, 0.84; 95%CI, 
[0.75, 0.94]) and AD (HR, 0.78; 95%CI, [0.66, 0.92]), but not for VaD (HR, 0.88; 95%CI, 
[0.71, 1.09]) (42).  
1.2.3.1 Study in Canada 
The only study in Canada that evaluated the association of O3 with dementia is the 
population-based cohort study by Chen et al. that included over two million residents of 
Ontario. This study did not find any association between exposure to O3 and incidence of 
dementia (HR, 0.98; 95%CI, [0.96–1.00]; per IQR of 6.3ppb) (46).  
1.2.3.2 First-Time Hospitalization With Dementia 
In the study by Cerza et al, the association between exposure to O3 and the first-time 
admission to hospital with the diagnosis of dementia was evaluated. Their results indicated 
a 6% increase in HR of dementia per 10μg/m3 increase in the mean annual exposure to O3 
(HR, 1.06; 95%CI, [1.03–1.08]). However, such an association was not found for AD (HR, 
0.98; 95%CI, [0.95–1.02]) and VaD (HR, 1.02; 95%CI, [0.98–1.06]) (51).  
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The contradictory results regarding the association of O3 with incidence of dementia 
indicate that there might be either a weak association between them or there are other 
factors that modify the association of O3 with dementia by either attenuating or 
strengthening its effects.  
1.2.4 Meta-analyses of the Association of Air Pollution and 
Incidence of Dementia 
Although numerous systematic reviews have evaluated the association between air 
pollution and dementia, the meta-analyses on such an association had been scarce at the 
time of formulating this study. Shortcomings of pre-existing meta-analyses include 
heterogeneity of assessments and methodology, as well as a limited number of included 
studies.  
In a systematic review and meta-analysis by Tsai et al. in 2019, the association of PM2.5 
with dementia was evaluated. They searched six databases and included four studies (39, 
42, 46, 50) in their meta-analysis. Using a random-effects model, they reported that by a 
10μg/m3 increase in PM2.5, the incidence of dementia would increase by 326% (HR, 3.26; 
95%CI, [1.20, 5.31]). In addition, there was a statistically significant association between 
exposure to PM2.5 and incidence of dementia (HR, 4.82; 95%CI, [2.28, 7.36]) (73). The 
high pooled HR in this study might be due to using 10 units increase in levels of PM2.5 that 
might be beyond what the original data meant to present. Moreover, converting the original 
HR to the new increment, i.e. 10μg/m3, might not be accurate and conversion to log and 
back to estimates might provide extraordinarily large values for the new estimate. In 
24 
 
addition, the small number of included studies makes the results prone to favour larger 
estimates in the included studies. 
Another meta-analysis by Fu et al. (74) on the association between PM2.5 exposure and 
neurological disorders in 2019 included five studies in their final model: three in meta-
analysis for dementia (46, 50, 75) and three for AD (39, 50) with one of them being 
included in both models (50). The study reported an increased HR of dementia (HR, 1.16; 
95%CI, [1.07, 1.26]) and AD (HR, 3.26; 95%CI, [0.84, 12.74]) per 10μg/m3 increase PM2.5 
levels. In addition to the concerns raised regarding the previous meta-analysis, one of the 
included studies (75) had overlapping data with a previous study, but reported the adjusted 
HR of dementia for road proximity and therefore, should have been excluded from their 
meta-analysis.  
Although no completed meta-analyses on the association of other air pollutants, namely, 
PM2.5, NOX, and O3, with incidence of dementia or its subtypes in cohort studies, a few are 
ongoing at the time of writing this report. The recency of the issue, discrepant reports from 
around the world, and lack of an updated meta-analysis suggests that an updated systematic 
review and meta-analysis is needed in order to include recent studies with valid methods 
of synthesis in order to direct appropriate attention toward the important potential 
associations between air pollutants and incidence of dementia based on best available 
evidence.  
1.3 Objectives 
This study aimed to evaluate the association between exposure to three main outdoor air 
pollutants, i.e., PM2.5, NOX, and O3, with incidence of dementia or its subtypes by 
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evaluating the cohort studies on individuals over 40 years old that have reported HR as 
their outcome. The aim of this systematic review and meta-analysis was to evaluate the 
association between air pollution with incidence of dementia or its subtypes amongst 
individuals over 40 years of age in population-based cohort studies.  
The results of this study will be beneficial for scientists who want to conduct studies on the 
association of exposure to air pollution and dementia because this study informs them of 
the gaps and flaws of the previous studies and guides them to devise future studies. In 
addition, the public health authorities and government will be able to evaluate the current 
evidence and plan for future actions. Moreover, the citizens of the world will be aware of 





Chapter 2  
2 Materials and Methods 
This study aimed to evaluate the association of dementia with particulate matter 2.5 
(PM2.5), nitrogen oxides (NOX), nitrogen dioxide (NO2) and ozone (O3) in a systematic 
review and meta-analysis. The protocol of the study was registered in PROSPERO with 
the registration number CRD42020219036. 
2.1 PECO 
In this study, the PECOS (population, exposure, controls, outcome, and study design) was 
defined as follows: 
P:  Adults over 40 years of age, from any country, whether urban or rural; 
E:  Exposure to higher levels of air pollutants, including any one or more of PM2.5, NOx, NO2, 
or O3;  
C:  Exposure to lower levels of these air pollutants; 
O:  Incidence of dementia or its subtypes, as reported by hazard ratios (HR); and 
S:  Cohort studies (retrospective, prospective, population-based, and registry-based). 
The search was not limited to any specific period, or by language.  
2.2 Searching Databases and Data Extraction 
2.2.1 Information sources 
The search strategy was designed and executed in collaboration with medical librarians at 
Western University. The search was conducted twice (April 2020 and August 2020). The 
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first search was very broad and was performed to identify different types of air pollutants 
and study types. Based on the papers that met inclusion criteria during screening of the 
results from the first search, we conducted a second search to include more specific terms 
for the most commonly-studied pollutants, as well as to further focus the study design 
toward cohort studies only. Databases searched included PubMed (1809 - present), 
MEDLINE (1946 – present), EMBASE (1947 – present), PsycINFO (1806 – present), 
Scopus (1788 – present), and Web of Science (1900 – present). We also searched gray 
literature for unpublished work and dissertations. At the data extraction step, we also 
contacted some of the authors for additional information or incremental HR when the study 
had reported categorical comparisons between high exposure and low exposure. The final 
search was completed on August 15, 2020.  
2.2.2 Search Strategy 
The search strategy included the combination of terms for the outcome and terms for the 
exposure. PubMed was searched with the following terms:  
("Alzheimer Disease"[Mesh] OR "Dementia"[Mesh] OR alzheimer* OR dementia) AND 
("air pollution"[MeSH Terms] "Particulate Matter"[ MeSH Terms] OR "Nitrogen Oxides"[ 
MeSH Terms] OR "Nitrogen Dioxide"[ MeSH Terms] OR "Nitrous Oxide"[ MeSH Terms] 
OR "Ozone"[ MeSH Terms] "Petroleum"[ MeSH Terms] OR "Sulfur Oxides"[ MeSH 
Terms] OR (air pollut*) OR (Particulate Matter*) OR (Nitrogen AND (Oxide* OR 
dioxide*)) OR (Nitrous AND Oxide*) OR (Ozone) OR (Sulfur AND Oxide*) OR smok* 
OR "Cooking"[Mesh] OR cooking* OR "environmental pollution"[MeSH Terms] OR 
"Environmental Pollutants"[Mesh Terms] OR "Environmental Exposure"[Mesh] OR 
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"traffic-related pollution"[MeSH Terms] OR "Vehicle Emissions"[Mesh Terms] OR 
traffic-related OR traffic* OR car* OR Vehicle* OR road* OR transport* OR road-
proximity OR "Fossil Fuels"[Mesh] OR "Petroleum Pollution"[Mesh] OR gas OR 
gasoline* OR diesel* OR fossil* OR petroleum* OR fuel* OR environment* OR "PM2.5" 
or PM10 or NOx OR NO2) AND (pollut* OR exposur* OR emission*). 
No filters were used to limit the study by language, study type, or year of publication. The 
search terms for other databases are provided in Appendix A. 
2.2.3 Study Selection 
After completing the search, the results were imported to a reference manager software 
(EndNote). Screening was performed by two independent reviewers. First, the duplicated 
studies were removed. The title and abstract of the studies were assessed and irrelevant 
papers were removed. Then the full texts of the remained papers were examined and 
included studies were subjected to data extraction and decision on inclusion in the meta-
analysis. 
2.2.4 Data Collection Process 
Data from included studies were extracted onto an Excel spreadsheet. The pilot form was 
used in the first pass on three papers, and after reflection, other items were added or 
modified to make the final form. The final form was used by one author for extracting the 
data from the rest of the papers. A second investigator read the full texts and verified the 
data entry.  
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Some of the papers did not use increments of air pollutants in their estimation of HR. 
Instead, they compared the highest exposure with the lowest exposure. To have a better 
estimation of the HR, we contacted the authors to request more detailed estimates. 
2.2.5 Data items 
The following data were extracted from each included study: 1) study identifiers: Author 
surname, year of publication, type of cohort (prospective or retrospective), and name of the 
study or cohort if available; 2) characteristic of the studied population: country, 
state/province, and city, included population, age at baseline; 3) information on exposure: 
studied pollutants, method of pollutant measurement, exposure period, units of 
measurement, and the correlation coefficient between pollutants if more than one pollutant 
was studied; 4) information on those with a lower level of exposure; 5) information on the 
outcome: follow-up period, the incidence of dementia and its subtypes, age at the time of 
diagnosis, applied statistical tests, and hazard ratio according to the increment of pollutants.  
2.3 Risk of Bias in Individual Studies 
To ascertain the validity of the included studies, the risk of bias was assessed by “Tool to 
Assess Risk of Bias in Cohort Studies”. The tool is devised by the CLARITY Group at 
McMaster University and comprises eight questions, each of which addresses a different 
type of bias and has four possible answers: Definitely yes (low risk of bias); Probably yes, 
Probably no, and Definitely no (high risk of bias). According to the answers to each 
question, the studies were assigned to high, moderate, or low risk of bias. The risk of bias 
assessment was performed independently by two authors. The information was used to 
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prioritize the studies that could be included in the study or should be removed in sensitivity 
analysis. 
2.4 Statistical Analysis 
2.4.1 Summary Measures 
The primary outcome measure was HR for incidence dementia and its subtypes, estimated 
by the Cox proportional hazard model or its derivatives. This study aimed to evaluate 
whether HR for dementia was associated with increasing pollutant levels. When enough 
information on the HR of dementia with an increase in levels of air pollutants was not 
available, we contacted the authors for additional estimations. The summary measure was 
the pooled HR for the incidence of dementia and its subtypes using the random-effects 
model. 
2.4.2 Converting Units of Measurement and Making the Estimates 
Comparable Across Studies 
To make the reported estimates by included studies comparable, we made some changes 
to the increments of air pollutants. PM2.5 is mainly reported in μg/m
3 and hence, the same 
unit of measurement was used and if any study had reported the level of PM2.5 in ppb, we 
would convert it to μg/m3 (Table 1). To make the studies on PM2.5 comparable, HR and 
95% CI were estimated for a 1-unit increase in PM2.5 level. For exposure to NOX, exposure 
units were converted to μg/m3 and HR and 95% CI were estimated for a 10-unit increase 
in NOX level. For NO2, the unit of exposure in μg/m
3 was converted to ppb and HR and 
95% CI were estimated for a 10-unit increase in NO2 level. The unit of O3 measurement 
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was converted from pbb to μg/m3 and HR estimate and 95% CI were calculated for 10-unit 
changes in O3 level. 
 
Table 1. Conversion of the Units of Measurement for Studied Air Pollutants 
Pollutant Levels in ppb levels in μg/m3 
PM2.5 1 1 
NOx 1 1.91 
NO2 1 1.9125 
O3 1 1.9957 
 
The formulae that were used to convert the reported estimates to new estimates based on 
the new increments were as follows: 
• For converting the original HR to HR for the new increment of pollutants, the 
natural logarithm of the HR was calculated, multiplied by the new increment, and 
then divided by the original increment (HRO, original HR; HRN, New HR; IO, old 
increment; and IN, new increment): 






• For converting confidence levels to new confidence levels, the following formulae 
were used (LCL, lower confidence level; UCL, upper confidence level; O indicates 






𝑙𝑛(𝐿𝐶𝐿𝑂) − (𝛽 × 𝐼𝑂)
1.96 × 𝐼𝑂
 
95% 𝐿𝐶𝐿𝑁 = 𝑒𝑥𝑝[(𝛽 × 𝐼𝑁) − (1.96 × 𝑆𝐸 × 𝐼𝑁)] 
95% 𝑈𝐶𝐿𝑁 = 𝑒𝑥𝑝[(𝛽 × 𝐼𝑁) + (1.96 × 𝑆𝐸 × 𝐼𝑁)] 
2.4.3 Meta-analysis and Subgroup Analysis 
The meta-analysis for computing pooled HR uses the inverse variance of each study 
estimate and therefore, the natural logarithm of HR estimate and standard error of each 
included study were introduced to RevMan (Review Manager [Computer program]. 
Version 5.4. The Cochrane Collaboration, 2020) for calculating the pooled HR estimates. 
The studies had included populations from different parts of the world, and they were 
clinically heterogeneous with regard to measuring exposure and reported outcome. 
Therefore, the random-effects model was used to estimate the pooled HR. The pooled HR 
for dementia was estimated separately for each pollutant.  
The included studies had reported on different outcomes, namely, the incidence of 
dementia, first-time hospitalization with dementia, and subtypes of dementia such as 
Alzheimer’s disease (AD), vascular dementia (VaD), and non-Alzheimer dementia (NAD). 
The main goal of this meta-analysis was to provide a pooled estimate of HR for studies that 
reported on the association between air pollution and dementia, irrespective of the subtype 
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of dementia and incidence of hospitalized or non-hospitalized cases of dementia. It is 
noteworthy that a recent study has shown that cases that were classified as AD 
demonstrated the neuropathological features of other types of dementia in autopsy 
examination (5) and therefore, relying on the clinical classification of subtypes of dementia 
might be misleading. Moreover, most of the studies had reported on the HR for dementia 
as well as for its subtypes which enabled subgroup analysis to evaluate the effect of each 
outcome on the pooled HR. 
Whenever the study had reported on the HR for dementia, this estimate was used in the 
meta-analysis to estimate pooled HR. Whenever they had reported on only subtypes of 
dementia, that subtype was included in the analysis as a subgroup. In addition, studies that 
reported on the HR of the first-time hospitalization with dementia were included as a 
subgroup in the analysis. For each pollutant, HR estimates were calculated for dementia 
and its subgroups. Moreover, because the geographic region might affect the incidence of 
dementia, the subgroup analysis was performed according to the country/continent where 
the study was conducted. 
We planned to perform a meta-analysis according to the decades that the exposure 
happened and evaluate the trend of changes in pollutants levels and incidence of dementia. 
Moreover, we planned to evaluate and compare the association of long-term exposure to 
air pollutants with incidence of dementia between males and females.  
2.4.4 Assessing Heterogeneity Across Studies 
The heterogeneity in effect size across the included studies was quantified by Ι2 and 
reported for all the meta-analyses as well as subgroup analyses. Ι2 was interpreted as a 
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continuous scale, with higher values inferring higher heterogeneity in effect size across 
studies. The advantage of Ι2 to other statistics of assessing heterogeneity such as Q and τ2 
is that it is neither sensitive to the number of studies nor to the scale of measurement as it 
is the ratio of true heterogeneity to the total variation in observed effects (76).  
2.4.5 Risk of bias across studies 
For each study, the HR was plotted against its inverse standard error to create a funnel plot, 
which was inspected visually for each studied pollutant for visual evidence of potential 
publication bias. In addition, “metabias” package in Stata 16SE (StataCorp. 2019. Stata 
Statistical Software: Release 16. College Station, TX: StataCorp LLC.) was used to 
perform Egger’s test to explore whether there is evidence of a small study-effect indicative 
of publication bias, , where a p-value < 0.10 would indicate small studies are missing from 
the available set of identified studies. 
2.4.6 Additional Analyses 
Sensitivity analyses were performed to evaluate robustness of the pooled estimate to the 
presence or absence of studies according to predefined variables. Since studies were 
heterogeneous regarding the included population and outcome of the study, studies with a 
small population were removed one-by-one from the meta-analysis and the effect on the 
pooled HR was examined. In addition, studies from certain parts of the world, for instance, 
Asia, were removed to examine the robustness of the pooled effect measure to potential 
geographic reporting differences. Because some studies had reported outcomes other than 
total incidence of dementia, they were also subjected to sensitivity analysis to examine the 
effect of differing definitions on the pooled estimates.  
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Chapter 3  
3 Results 
3.1 Study selection 
The search was completed on August 14, 2020. Searching PubMed yielded 3,368 papers. 
Web of Science and Scopus database search resulted in 1,078 and 164 papers. Medline, 
Embase, and APA PsycInfo were accessed through Ovid Lippincott Williams & Wilkins 
Total Access Collection and yielded 1,008 papers. After removal of 1,174 duplicate papers, 
4,462 papers were assessed for eligibility. Finally, a total of 16 papers were selected for 
full text review.  
Of the studies collected for full-text review, two papers did not report the incidence of 
dementia for increments of NO2 or PM2.5 and were excluded from the meta-analysis. A 
study by Oudin et al. on the Betula Cohort in 2016 (64) was excluded from the meta-
analysis because an update to the data was published by the same author in 2019 where the 
authors examined the role of APOE ϵ4 on the association estimate (65). The reasons for 




Figure 1. PRISMA Flow Chart of Review Process and Screening Papers 
 
3.2 Study Characteristics 
The characteristics of the included studies are presented in Tables 2 to 5. Finally, a total of 
16 population-based cohort studies, all published in English, were included in this 
systematic review and 13 were included in the meta-analysis. During the data extraction, 
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some information from almost every study was not reported in papers or supplementary 
information. In total, authors from eight studies provided additional information for our 
analysis. Since the studies were population-based cohorts, access to the data was generally 
limited to the time of study, and authors could not add additional information.  
The years of recruitment of included cohorts at baseline ranged from 1993 to 2005 and the 
endpoint of cohorts ranged from 2003 to 2013. The longest cohorts were from the Betula 
project, Umea, Sweden, that followed the population for 17 years (41, 64-66). The studies 
were conducted on the population of the following countries: Sweden (5 studies) (41, 43, 
64-66), Canada (4 studies) (46-49), the United States (3 studies) (40, 50, 52), Taiwan (2 
studies) (39, 63), the United Kingdom (51), and Italy (51).  
3.2.1 Population 
The total population in the included studies was 28,285,298. Included individuals were ≥ 
45 years and free of dementia at baseline, for whom the data on exposure to air pollution 
was available. Both sexes were included in the included studies except the study by 
Cacciottolo et al. (40) that examined the association of PM2.5 with cognitive impairment of 
women within the Women’s Health Initiative Memory Study (WHIMS). The mean (SD) 
of age at baseline was not reported in some studies and contacting the authors did not yield 
additional information for most of them. Moreover, some studies reported age as a 
categorical variable and data on baseline age were presented as the frequency of individuals 
in the specific age groups (Table 2 and 3).  
The latest endpoint in included studies was 2013 which seems reasonable due to the 
registry-based design of the cohorts and since such data need time to be collected, cleaned, 
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and become available to researchers. In addition, a lengthy time of acquisition and 
analyzing such data might cause several years of delay in reporting the results. Therefore, 





Table 2.Information on Included Studies a  









Betula Cohort  Sweden 68.5 (9.4) 
Range, 55-
85;  
1993 the second test wave T2 (1993–1995), where 
sample 3 (S3) was introduced, and sample 1 
(S1) was tested for the second time. 
2010 
Cacciottolo 
et al. (2017) 
(40) 
WHIMS US, 48 states Range, 65-79 1995 Community-dwelling women of ε3/3, ε3/4, and 
ε4/4 alleles of European ancestry (primarily 
non-Hispanic whites) with complete PM2.5 
exposure estimates 
2010 
Carey et al. 
(2018) (42) 
CPRD London, UK 62.1 (8.4); 
range, 50-79 
2005 Individuals in 75 practices who had been 
registered for 1 year continuously with their 
practice. 
2010 
Cerza et al. 
(2019) (51)  
NA Rome, Italy 74.5 (6.9) 
 
  
2001 All residents in Rome who were ≥ 65 years old 
and filled out the questionnaire of the 
population census from 2001. 
2013 
Chang et al. 
(2014) (77) 
A subset of 
NHIRD 
Taiwan 61.4 (8.5) 2000 Individuals ≥ 50 years or older for whom 
estimable air pollution data were available but 
did not present a history of head injury, stroke, 
dementia before 2000 
2010 
a Abbreviations: NA, Not available; CPRD, The Clinical Practice Research Datalink; NHIRD, the National Health Insurance Research Database; 
and WHIMS, The Women’s Health Initiative Memory Study. 





Table 2. Information on Included Studies a (Continued) 




Included papulation Endpoint 
Chen et al. 
(2017) (46)  
ONPHEC Ontario, Canada 66.8 (8.2); 
Range, 55-85 
2001 Canadian-born individuals who resided in 
Ontario for> 5 years and were registered with 
provincial health insurance 
2013 
Grande et al. 
(2020) (43)  
SNAC-K Stockholm, Sweden 74.1 (10.7) 2001 Residents of the Kungsholmen district in 
central Stockholm from March 21, 2001, 
through August 30, 2004, and 60 ≥ years 
2013 
Ilango et al. 
(2020) (47)  
NA Ontario, Canada 60.19 (10.56) 1996 Canadian-born Ontario residents who 
participated in the 1996–97 cycle of the 
National Population Health Survey (NPHS) 
and 2000/01, 2003 and 2005 cycles of the 
Canadian Community Health Survey (CCHS). 
if they lived in Ontario for at least 5 years and 
were ≥45 years or older at the date of survey 
(i.e. study baseline). 
2013 
Jung et al. 
(2015) (39) 
LHID2000 Taiwan NA 2001 Individuals from LHID2000 
aged ≥65 years at the baseline 
2010 
Kioumourtzog
lou et al. 
(2016) (50) 
NA US (50 cities) 
across the 
northeastern US) 
75.6 (7.6) 1999 Fee-for-service Medicare enrollees (≥ 65 years 
old) 
2010 
a Abbreviations: NA, Not available; LHID2000, The longitudinal health insurance database 2000; ONPHEC, Ontario Population Health and 
Environment Cohort; and SNAC-K, Swedish National Study on Aging and Care in Kungsholmen. 
b Data are presented as mean (SD) and range if available. 
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Included papulation Endpoint 
Lee et al. 
(2019) (52)  
NA Seven states of 
Southeastern US 
(AL, FL, GA, MS, 
NC, SC, and, TN) 
70.4 (7.3) 2000 Beneficiaries of the Medicare fee-for-service 
(FFS) plan who were aged ≥ 65 y and resided 
in the southeastern part of the United States 
between 2000 and 2013. 
2013 
Oudin et al. 





Range, 55-85 1993 Participants who were > 55 years from samples 
S1, S2, and S3 gathered at T2 
2010 
Oudin et al. 





Range, 55-85 1993 The second test wave T2 (1993–1995), where 
sample 3 (S3) was introduced, and sample 1 
(S1) was tested for the 2nd time.  
2010 
Oudin et al. 







1993 The second test wave T2 (1993–1995), where 
sample 3 (S3) was introduced, and sample 1 
(S1) was tested for the 2nd time. 
2010 
Smargiassi et 
al. (2020) (49) 
NA Quebec, Canada 69.70 (6.76) 2000 Adults ≥ 65 years who lived in Quebec for the 
last four years (Open Cohort) 
2012 
Yuchi et al. 
(2020) (48) 




1994 All adults aged 45–84 years old who resided in 
Metro Vancouver, registered with MSP, and 
had lived in Metro Vancouver during the 
exposure period 
2003 
a Abbreviations: NA, Not available; CPRD, The Clinical Practice Research Datalink 
b Data are presented as mean (SD) and range if available. 
42 
 
Table 3. Information on Included Studies a 








Adjusted covariates Age at 
Diagnosisb 
Andersson et al. 
(2018) (66) 
DSM-IV  NA 1993-2010 Cox 
proportional HR 
adjusted for baseline age, education, physical 
activity, smoking, sex, BMI, WHR, alcohol, 
and ApoE4, for baseline medical history of 
DM, HTN, and stroke. 
NA 
Cacciottolo et 





9.9 1999-2010 Cox 
proportional HR 
age, geographic region, education, income, 
employment status, lifestyle factors (smoking; 
alcohol use; physical activities) and clinical 
characteristics (use of hormone treatment, 
depression, BMI HCL, HTN, DM, and 
histories of CVD) 
NA 
Carey et al. 
(2018) (42) 
ICD10  
Read codes for dementia 
within QOF.  
6.9 2005-2013 Cox 
proportional HR 
Age, sex, ethnicity, smoking, alcohol, BMI and 
Index of Multiple Deprivation. 
77.2 (6.2) 
Cerza et al. 
(2019) (51)  
ICD-9-CM 10.6 2001-2013 Cox 
proportional HR  
Age, sex, education, place of birth, marital 
status, area-based socioeconomic position 
77.1 (6.5)  
Chang et al. 
(2014) (77) 
ICD-9-CM NA 2000-2010 Cox 
proportional HR 
Age, sex, monthly income, DM, IHD, HTN, 
COPD, alcoholism and urbanization 
61.4 (8.5) 
a Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; DM, diabetes mellitus; HR, hazard 
ratio; HCL, hypercholesterolemia; HTN, hypertension; IHD, ischemic heart disease; NA, not available; WHR, waist-hip ratio; and WHIMS, the Women’s 
Health Initiative Memory Study.  
b Data are presented as mean (SD) if available unless stated otherwise 
43 
 
Table 3. Information on Included Studies a (Continued) 








Adjusted covariates Age at 
Diagnosisb 
Chen et al. 
(2017) (46)  
population-based health 
administrative databases 
with a validated algorithm 




Age, sex, and stratified region, neighborhood-
level income, education, unemployment rate, 
Urban residency and a North/South indicator, 
pre-existing brain injury, stroke, DM, HTN, 
CAD, heart failure, and arrhythmia, and 
Indirectly adjusted for smoking, physical 
activity, obesity, and education (Model 5) 
73.8 (6.9) 
Grande et al. 
(2020) (43)  
Dementia: DSM-IV  
AD: according to 
NINDS/ADRD criteria 
VaD: NINDS and ARN  
6.01 (2.56) 2001-2013 Cox 
proportional HR 
Age, sex, educational attainment, smoking, 
physical inactivity, SES, early retirement, 
BMI, depression, baseline MMSE score, and 
cardiovascular risk factors 
Dementia: 
83.1 (7.4)  
Ilango et al. 
(2020) (47)  
Patients’ records in the 
registry 
10.6(3.7) 2002-2013 Cox 
proportional HR 
and an Aalen 
additive hazards 
model  
Age, sex, education, marital status, income 
quintile, smoking status, BMI, physical 
activity, rural residence and northern region; 
area level: recent immigrants, unemployment 
and education. 
NA 
a Abbreviations: ADRD, Alzheimer’s Disease and Related Disorders Association; ARN, Association Internationale Pour la Recherché et l`Enseignement en 
Neurosciences; BMI, body mass index; CAD, coronary heart disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HR, hazard 
ratio; HTN, hypertension; IHD, ischemic heart disease; NINDS, the National Institute of Neurological and Communicative Diseases and Stroke; MMSE, 
Mini-Mental State Examination; and NA, not available.  
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Adjusted covariates Age at 
Diagnosisb 




CM, DSM-IV, Hachinski 
ischemic score 
NA 2000-2010 Cox 
proportional HR 
age, gender, income, DM, HTN, MI, stroke, 
asthma and COPD 
NA 
Kioumourtzoglo
u et al. (2016) 
(50) 





Age, sex, race, year of follow-up, any previous 
admission for CHF, COPD, MI, or DM and 
number of days spent in intensive and coronary 
care units, ZIP-code level median income as a 
proxy for SES.  
NA 
Lee et al. (2019) 
(52)  
ICD-9_CM Median, 6 2000-2013 Extended Cox 
Model 
(Andersen-Gill) 
Age, sex, race, Medicaid eligibility, 
educational attainment at the Zip Code level, 
and U.S. state of address. 
82.2 
Oudin et al. 
(2016) (64)  
DSM-IV 11.4 1993-2010 Cox 
proportional HR 
Baseline age, education, physical activity, 
smoking, sex, BMI, WHR, alcohol, ApoE4, 
medical history of DM, HTN, and stroke. 
NA 
a Abbreviations: ADRDA, Alzheimer’s Disease and Related Disorders Association; CHF, congestive heart failure; COPD, chronic obstructive pulmonary 
disease; DM, diabetes mellitus; HR, hazard ratio; HTN, hypertension; MI, myocardial infarction; MMSE, Mini-Mental State Examination; NINCDS, the 
National Institute of Neurological and Communicative Diseases and Stroke; NA, not available; SES, socioeconomic status.  
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Adjusted covariates Age at 
Diagnosisb 
Oudin et al. 
(2018) (41)  
DSM-IV 11.4 1993-2010 Cox 
proportional HR 
Age, Education, physical activity, smoking, 
sex, BMI, WHR, and alcohol consumption, 
APOE4  
NA 
Oudin et al. 
(2019) (65)  
Registry files 
ICD-9 and ICD-10 
7.3(4.3) 2000-2013 extended Cox 
proportional HR 
stratified for sex, adjusted for calendar year, 
and indexes of social and material deprivation. 
NA 
Smargiassi et al. 
(2020) (49) 
ICD-9 or ICD-10  NA 1999-2003 Cox 
proportional HR 
Age, sex, comorbidities (TBI, DM, HTN, 
stroke, CAD, CHF, and arrhythmia), 
household income, education and ethnicity 
Median, 76  
a Abbreviation: BMI, body mass index; CAD, coronary heart disease; CHF, congestive heart failure; DM, diabetes mellitus; HR, hazard ratio; HTN, 
hypertension; NA, not available; TBI, traumatic brain injury; WHR, waist-hip-ratio 





Among the included studies, four, three, and one exclusively reported on exposure to PM2.5 
(40, 41, 50, 52), NOX (64-66), and NO2 (63), respectively. Other studies reported on two 
or more exposures and few studies reported correlation coefficient between pollutants. 
Exposure was measured through various methods. For most of the studies, a land use 
regression (LUR) model was used to assign the concentration of the pollutants to the postal 
code of the residents. These measurements have their limitations and assigning the 
pollutant level to a specific area was not similar among studies. Some studies used 
information from satellites along with data from pollutant measuring stations to estimate 
the population exposure in each residential area (Table 4). While the exposure period was 
not clearly separated from the follow-up period in most of the studies, a study by Lee et al. 
on the association of PM2.5 and dementia considered a five-year-lag before developing 
dementia as the exposure period (52). Additionally, Ilango et al. examined the mediating 
role of cardiovascular diseases (CVD) in developing dementia after exposure to No2 and/or 
PM2.5. They considered a three-year exposure before a five-year lag for developing 
dementia during which the CVD could develop (47).  
3.2.3 Controls 
In all included studies, the incidence of dementia was evaluated against those who had 
not developed dementia by Cox proportional hazard regression model or its derivatives 
(Table 3). Since almost everyone in the population was exposed to some degree to the air 
pollutants, some studies categorized the exposure according to the level of exposure. 
When the exposure level was used as a categorical variable in the regression models and 
the hazard ratio (HR) for unit(s) increase in air pollutants was not available, the authors 
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were contacted for an estimate of HR per increments of pollutants and four authors 
responded and sent the requested estimates The information on two studies that had 
reported the categorical levels of exposure (40, 63) could not be obtained and therefore, 
they were excluded from the meta-analysis. Overall, eight authors responded to our 





Table 4. Information on Evaluated Pollutant, Exposure Measurement, and Exposure Period a 
Author, Year Pollutants Measures of Exposure Exposure 
period 
Andersson et al. 
(2018) (66) 
NOx LUR model based on measurements during a four-week long period between 
November 2009 and June 2010.  
1993-2010 
Cacciottolo et al. 
(2017) (40) 
PM2.5 A spatiotemporal model that integrated AQS and the output of chemical transport 
models to at all WHIMS residential locations in 1999–2010.  
1999-2010  





Modelled annual concentrations for air pollutants were estimated using the KCL 
urban dispersion modelling system at a resolution of 20×20 m from 2004-2010 
2004-2010 







PM2.5 was measured in 20 sites, and NOx was measured in 40 sites in three two-
week periods during 2010.  
To estimate summer daily ozone (8 h) exposure FARM was used. 
2001-2013 
Chang et al. (2014) 
(77) 
NO2 Data from 74 ambient air quality monitoring stations were used. Yearly average 
concentrations of pollutants were calculated from the baseline to the end of the 
study 
2000-2010 
a Abbreviations: AQS, air quality system; FARM, Flexible Air quality Regional Model; LUR, land use regression; and WHIMS, the 





Table 4. Information on Evaluated Pollutant, Exposure Measurement, and Exposure Period a (continued) 
Author, Year Pollutants Measures of Exposure Exposure period 





PM2.5: information from satellite observations in combination with outputs from 
a global atmospheric chemistry transport model (GEOS-Chem CTM) producing 
an annual mean concentration of PM2.5 (1× 1 km) yearly between 1998 and 
2012. 
NO2: a national LUR model using NO2 observations at fixed-site monitors from 
National Air Pollution Surveillance Network. 
O3: Environment and Climate Change Canada has produced a long-term annual 
mean warm-season exposure surface of O3 (21 ×21 km) covering Canada 
between 2002 and 2009. 
1994-2013 
  
Grande et al. 
(2020) (43)  
PM2.5 
NOX 
Annual mean air pollution levels from local sources were calculated using 
emission inventories describing traffic and nontraffic sources for 1990, 1995, 
2000, 2005, and 2011. Annual mean levels of PM2.5 and NOX for 1990 through 
2011 were obtained from linear interpolation during the 4 years between each 
model simulation, and levels for 2012 and 2013 were set as of 2011. 
5 years 
a Abbreviation: LUR, land use regression  
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Table 4. Information on Evaluated Pollutant, Exposure Measurement, and Exposure Period a (continued) 
Author, Year Pollutants Measures of Exposure Exposure period 
Ilango et al. (2020) (47)  NO2 
PM2.5 
used previously estimated mean measurements of NO2 and PM2.5 at a spatial 
resolution of about 1 x 1km for each year between 1993 and 2013. 
Calculated averages of pollutant measurements over the three years leading 
up to the time of baseline survey completion.  
The 3-year average 
of pollutants with a 
5-year lag before 
dementia. CVD 
could develop in 
the 5-year period 
Jung et al. (2015) (39) PM2.5 
O3 
Hourly PM10 and O3 data available from 70 Taiwan EPA monitoring stations 
on Taiwan’s main island from 2000 through 2010.  
The mean ratio between PM2.5 and PM10 during 2006-2010 was used to 
estimate the concentrations of PM2.5 from 2000 to 2006.  
1999-2010 
Kioumourtzoglou et al. 
(2016) (50) 
PM2.5 PM2.5data obtained from the U.S. EPA and AQS database (U.S. EPA 2013). 
Annual PM2.5 averages within each city were estimated from 1999 through 
2010. 
1999-2010 
Lee et al. (2019) (52)  PM2.5 The observations from a satellite with a 1-km resolution were calibrated to 
PM2.5 data from ground monitors  
5 years before Dx 






Table 4. Information on Evaluated Pollutant, Exposure Measurement, and Exposure Period a (continued) 
Author, Year Pollutants Measures of Exposure Exposure period 
Oudin et al. (2016) (64)  NOX LUR model for Umeå to estimate the annual average levels 
of nitrogen oxides (NOX). 
  
Annual mean NOx concentration 
(estimated for 2009–2010) was used 
as a marker for long-term exposure 
to air pollution 
Oudin et al. (2018) (41)  PM2.5 They used data on the annual mean concentration of PM2.5 
for 1990, 2000 and 2010, calculated by the Swedish 
Meteorological and Hydrological Institute (SMHI).  
1993-2010 
measured at 1990, 2000, 2010 
Oudin et al. (2019) (65)  NOX A LUR model was used to estimate the concentration at the 
residence of each study person.  
Annual mean NOx concentration 
(estimated for 2009–2010) was used 
as a marker for long-term exposure 
to air pollution 




NO2: a national LUR model  
PM2.5: satellite imagery 
2000-2012 
Yuchi et al. (2020) (48) PM2.5 
NO2 
NO 
LUR models specific to Metro Vancouver were applied to 
estimate exposure to pollutants. monthly predicted air 
pollution concentrations were averaged to obtain air 
pollutant concentrations over the entire exposure period. 
1994-1998  
(January 1994–December 1998) 
a Abbreviation: LUR, land use regression.  
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3.2.4 Outcome  
Case ascertainment was not consistent among the studies. All cohorts were retrospective 
and therefore, the main method of categorizing dementia or its subtypes as a diagnosis was 
through examining administrative database or electronic health record diagnosis. In this 
sense, most of the studies used different versions of the International Classification of 
Diseases (ICD) according to the year of the study and development of codes. Other studies 
used DSM-IV criteria to diagnose dementia, alone or in combination with other tools such 
as ICD, MMSE, Hachinski ischemic score, or other validated algorithms (Table 3). 
The total incidence of dementia and its subtypes, namely, Alzheimer’s disease (AD), 
vascular dementia (VaD), and non-Alzheimer dementia (NAD), was 2,381,422 (11.88%) 
in a total population of 28,285,298. Some studies reported the incidence of AD and/or VaD 
as the sole outcome or as a subgroup of dementia with a total of 848,702 cases of AD and 
166,235 cases of VaD. Three studies reported the incidence of first-time hospitalization 
with dementia (50-52). The total incidence of the first first-time hospitalization with 
dementia was 1,634,610 (including 846,046 cases of AD and 165,420 cases of VaD) in a 
total population of 23,478,591. The total included population across all included studies 
was 28,285,298, and approximately 83% of the included population in this systematic 
review was from these three studies on the first-time hospitalization with dementia (Table 
5). 
It is noteworthy that four studies from Sweden (41, 64-66) used data from the Betula 
project, a population-based longitudinal study on memory, health, and ageing, and reported 
incidence of dementia and subtypes in association with exposure to different pollutants. 
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Hence, there might be overlap among included populations and reported cases of dementia 
and for calculating the total population and incidence of dementia and its subtypes, only 





Table 5. Population Included in Each Study and Number of Incidence Cases a 
Author, Year Included Population 
(n) 
Male, n (%) Outcome 
Dementia AD Vad NAD 
Andersson et al. (2018) (66) 1721 985 (57%) 302b  191 111 - 
Cacciottolo et al. (2017) (40) 3647 0 173 - - - 
Carey et al. (2018) (42) 130,978 65,130 (49.7%) 2181 848 634 - 
Cerza et al. (2019) (51)  350,884 145,994 (42%) 21,548 7,669 7,494 - 
Chang et al. (2014) (77) 29,547 13606 (46%) 1,720 - - - 
Chen et al. (2017) (46)  2,066,639 966,246 (46.8%) 257,816 - - - 
Grande et al. (2020) (43)  2,927 1082 (37%) 364 218 70 146 
Ilango et al. (2020) (47)  34,391 14,555 (42%) 2,559 - - - 
Jung et al. (2015) (39) 95,690 - - 1,399 - - 
Kioumourtzoglou et al. (2016) (50) 9,817,806  43.70% 203,463 266,725 - - 
Lee et al. (2019) (52)  13,309,901 5,871,658 (54.1%) 1,409,599 571,652 157,926 - 
Oudin et al. (2016) (64)  1806 773 (43%) - 191 111 - 
Oudin et al. (2018) (41)  1,806 773 (43%) - 191 111 - 
Oudin et al. (2019) (65)  1,567 687 (44) - 173 102 - 
Smargiassi, 2020 (49) 
   Quebec 










- - - 
Yuchi et al. (2020) (48) 633,949 300,192 (47%) - - - 13,170 
a Abbreviations: AD, Alzheimer’s disease; HR, hazard ratio; NAD, non-Alzheimer dementia; and VaD, vascular dementia. 
b Alzheimer’s disease and vascular dementia  
c First-time Hospitalized with the diagnosis of dementia and its subtypes. 
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3.3 Risk of Bias Within Studies 
Risk of bias was assessed in each study using the “Tool to Assess Risk of Bias in Cohort 
Studies” (78). According to our assessment, included studies had assigned the exposure to 
the residential address and the methods used for estimating exposure were not accurate. 
Therefore, all the studies bear some uncertainty in the assessment of exposure. Since the 
registry data was used to ascertain cases and assigning the codes might not be accurate, 
absence of the dementia at baseline and ascertainment of cases might not be free of error. 
This might also cause some misclassification of both cases and controls. In addition, each 
study adjusted for different variables at analysis level and some of the risk factors for the 
outcome were not adjusted for in the statistical analysis. The exact period and level of 
exposure that can cause dementia as well as the period between exposure and the clinical 
presentation of dementia is not fully known and the adequacy of the follow-up period 
would be uncertain. Hence, studies had an intermediate risk of bias in most of the assessed 




Table 6. The Assessment of the Risk of Bias Using Tool to Assess Risk of Bias in Cohort 
Studies a 
Authors, year 
Domains of Bias † 
1 2 3 4 5 6 7 8 
Andersson et al., 2018 (66)         
Cacciottolo et al., 2017 (40)          
Carey et al., 2018 (42)          
Cerza et al., 2019 (51)          
Chang et al., 2014 (77)         
Chen et al., 2017 (46)          
Grande et al., 2020 (43)         
Ilango et al., 2020 (47)          
Jung et al., 2015 (39)          
Kioumourtzoglou et al., 2016 (50)          
Lee et al., 2019 (52)          
Oudin et al., 2016 (64)          
Oudin et al. , 2018 (41)          
Oudin et al., 2019, (65)         
Smargiassi, 2020 (49)         
Yuchi et al., 2020 (48)          
⁕ Each question has four choices: Definitely yes, low risk of bias; Green; Probably yes, high 
intermediate risk, yellow; Probably no, low intermediate risk, pink; and Definitely no, high risk of bias; 
red. 
† Domains of bias; the Questions to be answered were:  
 1. Was selection of exposed and non-exposed cohorts drawn from the same population?  
 2. Can we be confident in the assessment of exposure?  
 3. Can we be confident that the outcome of interest was not present at start of study?  
 4. Did the study match exposed and unexposed for all variables that are associated with the outcome 
of interest or did the statistical analysis adjust for these prognostic variables?  
 5. Can we be confident in the assessment of the presence or absence of prognostic factors?  
 6. Can we be confident in the assessment of outcome?  
 7. Was the follow up of cohorts adequate?  





3.4 Results of Individual Studies 
Results of the individual studies are presented in Tables 7 to 10. All the included studies 
had used the Cox proportional hazard model or its derivatives to produce HR estimates. In 
addition, the level of exposure was not the same among the included studies. Therefore, 
some studies dichotomized and compared the higher level of exposure with a lower level 
of exposure or categorized the exposure into tertiles or quartiles for comparing different 
levels of exposure. Since most of the studies had reported HR in association with an 
increase in a certain level of pollutants, e.g., interquartile range (IQR), we excluded studies 
that did not report HR for incremental changes in pollutants if the authors did not or could 
not provide the estimates when they were contacted. Therefore, studies by Chang et al. (63) 




Table 7. Hazard Ratio and 95% Confidence Interval of Dementia and Its Subtypes Reported per Increment of PM2.5 in the 
Included Studies a 




Dementia AD VaD NAD 
Cacciottolo et al. (2017) (40) b 1.92 (1.32, 2.80) - - - 
Carey et al. (2018) (42) 0.95c 1.07 (1.02, 1.12) 1.10 (1.02, 1.18) 1.06 (0.97, 1.16) - 
Chen et al. (2017) (46)  4.8 1.03 (1.02, 1.04) - - - 
Grande et al. (2020) (43)  0.88c 1.54 (1.33, 1.78) - 1.66 (1.38, 1.99) - 
Ilango et al. (2020) (47)  10 1.29 (0.99, 1.64) - - - 
Jung et al. (2015) (39) 13.21c - 1.03 (0.95, 1.11) - - 
Oudin et al. (2018) (41)  1 1.14 (0.59, 2.23)d - - - 
Smargiassi et al. (2020) (49) 3.9c 1.02 (1.01, 1.03) - - - 
Yuchi et al. (2020) (48) 1.54c - - - 1.02 (0.980, 1.050) 
First-time Hospitalization      
Cerza et al. (2019) (51) 5 0.99 (0.96, 1.02) 0.91 (0.85, 0.97) 1.07 (1.01, 1.12) - 
Kioumourtzoglou et al. (2016) (50) 1 1.15 (1.10, 1.19) 1.07 (1.04, 1.11) - - 
Lee et al. (2019) (52)  1 1.049 (1.048, 1.051) 1.06 (1.057, 1.062) 1.086 (1.082, 1.09) - 
a Abbreviations: HR, hazard ratio; AD, Alzheimer’s disease; VaD, vascular dementia; and non-Alzheimer dementia. 
b Higher level of exposure (>12 𝛍g/m3) compared to the lower level; the study was excluded from the meta-analysis. 
c Per interquartile change in PM2.5. 




Table 8. Hazard Ratio and 95% Confidence Interval of Dementia and Its Subtypes Reported per Increment of NOx in the 
Included Studies a 




Dementia AD VaD 
Andersson et al. (2018) (66) b 1.41 (0.97, 2.03) - - 
Grande et al. (2020) (43)  8.35 c 1.14 (1.01, 1.29) - 1.09 (0.98, 1.3) 
Oudin et al. (2016) (64)  10 1.05 (0.98, 1.12)d 1.05 (0.97, 1.15) 1.02 (0.92, 1.14) 
Oudin et al. (2019) (65)  10 1.03 (0.97, 1.1) 1.04 (0.96, 1.13) - 
First-time Hospitalization     
Cerza et al. (2019) (51)  20 1.01 (1, 1.02) 0.96 (0.94, 0.98) 1.08 (1.06, 1.1) 
a Abbreviations: AD, Alzheimer’s disease; HR, hazard ratio; and VaD, vascular dementia. 
b Higher level of exposure (>26 𝛍g/m3) compared to the lower level (<9 𝛍g/m3); the HR (95% CI) for a 1-unit 
increase in NOx level was provided by the author.  
c Per Interquartile change. 






Table 9. Hazard Ratio and 95% Confidence Interval of Dementia and its Subtypes Reported per Increments of NO2 in the 
Included Studies a 
  HR (95%CI)  
 Author, year Increment Dementia AD VaD NAD 
Carey et al. (2018) (42) 7.47 μg/m3 b 1.16 (1.05, 1.28) 1.23 (1.07, 1.43) 1.15 (0.96, 1.39) - 
Chang et al. (2014) (77) c 1.54 (1.34, 1.77) - - - 
Chen et al. (2017) (46)  14.2 ppb 1.1 (1.08, 1.12) - - - 
Ilango et al. (2020) (47)  5 ppb 1.1 (0.99, 1.19) - - - 
Smargiassi et al. (2020) (49) 13.26 ppbb 1.015 (1.007, 1.023) - - - 
Yuchi et al. (2020) (48) 9.06 ppbb - - - 1.02 (0.99, 1.06) 
First-time Hospitalization      
Cerza et al. (2019) (51)  10 𝛍g/m3 0.98 (0.96, 0.99) 0.91 (0.89, 0.94) 1.05 (1.03, 1.07) - 
a Abbreviations: HR, hazard ratio; AD, Alzheimer’s disease; and VaD, vascular dementia.  
b Per interquartile change in NO2.  
c Higher level of exposure (>26 𝛍g/m3) compared to the lower level (<9 𝛍g/m3). 





Table 10. Hazard Ratio and 95% Confidence Interval of Dementia and its Subtypes Reported per Increment of O3 in the 
Included Studies a 
 HR (95%CI) 
 Author, year Increment Dementia AD VaD 
Carey et al. (2018) (42) 5.56 μg/m3 b 0.84 (0.75, 0.94) 0.78 (0.66, 0.92) 0.88 (0.71, 1.09) 
Chen et al. (2017) (46)  6.3 ppb 0.98 (0.96, 1.00) - - 
Jung et al. (2015) (39) 9.63 ppb b - 1.06 (1.00, 1.12) - 
First-time Hospitalization     
Cerza et al. (2019) (51)  10 𝛍g/m3 1.06 (1.03, 1.08) 0.98 (0.95, 1.02) 1.02 (0.98, 1.06) 
a Abbreviations: HR, hazard ratio; AD, Alzheimer’s disease; and VaD, vascular dementia. 





3.5 Synthesis of Results 
3.5.1 Particulate Matter with Diameter < 2.5𝛍 
The HR of dementia and/or its subtypes in association with PM2.5 was reported in 12 
studies. The study by Cacciottolo et al. (40) was excluded because it did not report the HR 
of dementia in association with a unit increase of PM2.5. Dementia was the reported 
outcome in nine studies, four of which also reported on VaD as the outcome. In addition, 
AD was reported in five studies, and was the only reported outcome in one study (39). 
Moreover, a study by Yuchi et al. reported NAD as the only outcome (48). Three studies 
reported on first-time hospitalization with dementia (50-52) and because of their large 
sample size, they affected the pooled estimate significantly.  
The pooled HR showed a statistically significant association between PM2.5 and incidence 
of dementia, either first-time hospitalized or any case of dementia (HR, 1.04; 95%CI: [1.02, 
1.06]; Ι2 = 100%). The largest estimate was seen in the subgroup that reported on the 
incidence of first-time hospitalization with dementia (HR, 1.06; 95%CI: [1.01, 1.10]; Ι2 = 
99%), which was expected because they were larger registry-based studies and comprised 
almost 80% of the study population. Such an association was statistically significant for 
studies that reported on incidence of dementia (HR, 1.02; 95%CI: [1.01, 1.03]; Ι2 = 95%).  
The p-value for subgroup interaction was significant (p-value = 0.02), indicating that the 
effect sizes for these subgroups are statistically different from one another, and indicating 





Figure 2. Subgroup analysis of hazard ratio per 1μg/m3 increase in PM2.5 level for all 
the studies that reported on the association of PM2.5 with incidence of any type of 
dementia and the incidence of the first-time hospitalization with dementia 
To further evaluate the effect of subtype of dementia on the pooled estimate, the studies 
that reported on AD, VaD, and NAD either as the main outcome or as a subgroup of 
dementia were included in the meta-analysis, while the studies that had reported only on 
dementia as the sole outcome were excluded. There was a significant association between 
exposure to PM2.5 and incidence of subtypes of dementia (HR, 1.06; 95%CI: [1.03, 1.08]; 
Ι2 = 99%); however, the association was statistically significant for VaD (HR, 1.15; 95%CI: 
[1.08, 1.23]; Ι2 = 99%) but not for the incidence of AD (HR, 1.04; 95%CI: [1.00, 1.08]; Ι2 
= 99%) (Fig. 3). 
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The p-value for subgroup interaction was significant (p-value = 0.001), indicating that the 
effect sizes for these subgroups are statistically different from one another, and indicating 
that differences in effect size were found according to definition of dementia.  
 
 
Figure 3. Subgroup analysis of hazard ratio per 1μg/m3 increase in PM2.5 for the 
studies that reported on the association of PM2.5 with Alzheimer’s disease, vascular 
dementia, and non-Alzheimer dementia 
The pooled HR was also estimated for studies from North America (six studies) (46-50, 
52), Europe (four studies) (41-43, 51), and Asia (one study) (39) to see if geographical 
region might have an effect on the estimates. Pooled estimates indicated a significant 
association between exposure to PM2.5 and incidence of dementia in studies from North 
America (HR, 1.03; 95%CI: [1.01, 1.06]; Ι2 = 100%). On the other hand, although the 
pooled estimate of the studies in Europe (United Kingdom, Italy, and Sweden) was large, 
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the confidence intervals were wide and the association was not statistically significant (HR, 
1.22; 95%CI: [0.94, 1.58]; Ι2 = 97%; Fig. 4). 
The p-value for subgroup interaction was significant (p-value = 0.02), indicating that the 
effect sizes for these subgroups are statistically different from one another, and indicating 
that differences in effect size were found according to the continent where the study was 
performed. 
 
Figure 4. Subgroup analysis of hazard ratio per 1μg/m3 increase in PM2.5 for the 
studies from different continents that reported on the association of PM2.5 with any 
type of dementia 
 
3.5.2 Nitrogen Oxides 
A total of four studies evaluated the association of exposure to NOX with the incidence of 
dementia (43, 51, 65, 66); however, one of the studies was the update to a previous study 
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(64, 65) and we only included one of them in the meta-analysis. In addition, one study 
reported first-time hospitalization with dementia as its outcome and was included in the 
meta-analysis as a subgroup. The study by Andersson et al. (66) measured NOX in μg/m
3 
and compared the highest levels of exposure with the lowest levels of exposure, and the 
author provided the HR estimate for one-unit and 10-unit increase in NOX level when he 
was contacted. The conversion of ppb to μg/m3 is challenging because the exact proportion 
of nitric oxide and NO2 should be known. Unfortunately, such information was not 
available and the conversion of ppb to μg/m3 for Andersson et al. was not possible due to 
inaccurate data based on general knowledge about the coefficient of conversion that was 
already reported. Since none of the individual estimates indicated a significant association 
between NOX and incidence dementia, the pooled estimate was also expected to show no 
statistically significant association (HR, 1.04; 95%CI: [0.98, 1.10]; Ι2 = 57%) either when 
the study by Andersson et al. was added (Fig. 5) or when the study by Cerza et al. (51) that 
reported on the first-time Hospitalization was introduced as a subgroup (Fig. 6).  
The p-value for subgroup interaction was non-significant (p-value = 0.13; Fig. 6), 
indicating that the effect sizes for these subgroups are not statistically different from one 
another, and indicating that differences in effect size were not found according to definition 





Figure 5. Pooled hazard ratio per 10 μg/m3 increase in NOX for the studies that 
reported on the association of NOX with dementia 
 
Figure 6. Pooled hazard ratio per 10μg/m3 increase in NOX for the studies that 
reported on the association of NOX with dementia when study on the first-time 




3.5.3 Nitrogen Dioxide 
A total of seven studies reported on exposure to NO2 (42, 46-49, 51, 63). Six studies 
reported on dementia (42, 46, 47, 49, 51, 63) and one study on NAD (48). In addition, the 
study by Chang et al. did not provide the HR for a unit increase in NO2 and was not included 
in the meta-analysis. (63). Moreover, only two studies reported on the incidence o AD and 
VaD as subtypes of dementia (42, 51). The pooled HR was estimated by including studies 
on the first-time hospitalization with dementia and a study that reported on the incidence 
of NAD as subgroups (Fig. 7). Although there was a significant association between the 
incidence of dementia and exposure to NO2 (HR, 1.07; 95%CI: [1.02, 1.12]; Ι
2 = 96%), 
such an association did not exist when studies that reported on NAD and first-time 
hospitalization with dementia were included in the meta-analysis (HR, 1.04; 95%CI: [1.00, 
1.08]; Ι2 = 96%).  
The p-value for subgroup interaction was significant (p-value < 0.001), indicating that the 
effect sizes for these subgroups are statistically different from one another, and indicating 





Figure 7. Subgroup analysis of hazard ratio per 10 μg/m3 increase in NO2 for the 
studies that reported on the association of NO2 with incidence of dementia, first-time 
hospitalization with dementia, and non-Alzheimer dementia 
 
3.5.4 Ozone 
The HR for association between O3 and dementia was reported in four studies (39, 42, 46, 
51), one of which reported only on the association with AD (39). Only the study by Creza 
et al. reported a significant association between exposure to O3 and incidence of first-time 
hospitalization with dementia (51). The pooled HR was estimated for all four studies where 
the study by Creza et al. on the first-time hospitalization with dementia and the study by 
Jung et al. on the incidence of AD (39) were introduced to the model as subgroups (Fig. 
8). No statistically significant association was found between exposure to O3 and dementia 
for two studies that reported on dementia (HR, 0.87; 95%CI: [0.70, 1.09]; Ι2 = 54%) and 
for all included studies (HR, 1.01; 95%CI: [0.91, 1.11]; Ι2 = 82%). The p-value for 
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subgroup interaction was non-significant (p-value = 0.12), indicating that the effect sizes 
for these subgroups are not statistically different from one another, and indicating that 
differences in effect size were not found according to definition dementia.  
 
Figure 8. Subgroup analysis of hazard ratio per 10 μg/m3 increase in O3 for the studies 
that reported on the association of O3 with incidence of dementia, first-time 
hospitalization with dementia, and Alzheimer’s disease 
Two studies reported on the incidence of AD and VaD as a subgroup of dementia (42, 51). 
The pooled estimate for these two subgroups did not yield any statistically significant 
association between exposure to O3 and the incidence of AD (HR, 1.02; 95%CI: [0.88, 
1.17] Ι2 = 75%) or VaD (HR, 1.02; 95%CI: [0.98, 1.06]; Ι2 = 0%) (Fig. 9).  
The p-value for subgroup interaction was significant (p-value = 1.0), indicating that the 
effect sizes for these subgroups are not statistically different from one another, and 





Figure 9. Subgroup analysis of hazard ratio per 10 μg/m3 increase in O3 for the studies 
that reported on the association of O3 with incidence of Alzheimer’s disease and 
vascular dementia 
 
3.6 Heterogeneity Across Included Studies 
Significant heterogeneity was found among studies that reported on the association 
between exposure to PM2.5 and incidence of dementia (Ι
2 = 95%), studies that reported on 
the incidence of the first-time hospitalization with dementia (Ι2 = 99%), and when all 
studies were included in the meta-analysis of the association between PM2.5 and incidence 
of dementia (Ι2 = 100%).  
There was also evidence of heterogeneity across studies that evaluated the association of 
dementia and its subtypes with the exposure to NO2 (Ι
2 = 96%) and O3 (Ι
2 = 82%). There 
was also a moderate heterogeneity among studies that evaluated the association of 
dementia with exposure to NOX (Ι
2 = 57%).  
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3.7 Risk of Bias Across Studies 
To evaluate the publication bias, funnel plots were created and evaluated (Fig. 10-13). It is 
noteworthy that the funnel could not be forced on the plots because of the small number of 
included studies. The plot indicated asymmetry in all studied pollutants. While the graphs 
indicate potential asymmetry for the association of each pollutant with dementia, the small 
number of studies makes it difficult to rule in or rule out publication bias. Overall, it appears 
that small negative studies are missing from the funnel plot, indicating potential publication 
bias. 
 
Figure 10. Funnel plot to evaluate publication bias in studies reporting on association 






Figure 11. Funnel plot to evaluate publication bias in studies reporting on association 
of exposure to NOX with incidence of dementia and its subtypes 
 
 
Figure 12. Funnel plot to evaluate publication bias in studies reporting on association 





Figure 13. Funnel plot to evaluate publication bias in studies reporting on association 
of exposure to O3 with incidence of dementia and its subtypes 
 
In addition, the risk of publication bias was evaluated by Egger’s regression test. The small-
study effect was significant only for studies reporting on the association of exposure to 
NOX with incidence of dementia. Publication bias estimates are limited by the small 
number of studies that were eligible for meta-analysis, suggesting that the Egger’s test will 








Bias Coefficient (95%CI) t P-value a 
PM2.5 11 4.97 (-6.13, 16.07) 4.74 0.43 
NOx 4 -14.77 (-27.1, -2.44) -3.50 0.07 
NO2 6 -16.24 (-80.18, 47.69) -0.54 0.62 
O3 4 17.03 (-32.21, 66.28) 1.01 0.42 
a Significance level is set at α > 0.10. 
3.8 Sensitivity Analyses 
The leave-one-out analysis was performed by excluding one study at the time and 
evaluating the effect on the subgroup pooled estimate compared to the overall pooled 
estimate. 
3.8.1 Particulate Matter with Diameter < 2.5𝛍 
The results of the sensitivity analysis for the association between exposure to PM2.5 and 
the incidence of dementia is summarized in Table 12 (the model is presented in Fig 2).  
In the leave-one-out analysis of the dementia subgroup, the pooled HR for the dementia 
subgroup ranged from 1.01 to 1.15 and the Ι2 ranged from 67% to 96%. Additionally, the 
pooled estimate for the overall association of exposure to PM2.5 ranged from 1.03 to 1.05 
with and Ι2 ranging from 99% to 100%. The leave-one-out analysis for the studies that 
reported on dementia as their outcome indicated that omitting the studies by Chen et al. 
(75) or Smargiassi et al. (49) would make the association between exposure to PM2.5 and 
dementia stronger by increasing the HR of dementia from 1.02 to 1.15, but would not 
meaningfully affect the overall pooled estimate. Nonetheless, these two studies were the 
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largest in this subgroup and the main observed HR in this subgroup can be attributed to 
them. Removing studies with a small sample size (41, 43, 47) did not meaningfully affect 
the subgroup and total estimations.  
Sensitivity analysis did show a significant change in the overall association when the study 
by either Jung et al. (39) or Yuchi et al. (48) was excluded from the model. On the other 
hand, removing any study that reported on the incidence of the first-hospitalization with 
dementia affected the subgroup estimate with pooled HR ranging from 1.02 to 1.10 and Ι2 
ranging from 94% to 100%; however, excluding any of these studies made the association 
in the subgroup statistically insignificant but did not meaningfully affect the overall 
estimate of the association with pooled HR ranging from 1.01 to 1.05 and Ι2 ranging from 
93% to 100%. 
In addition, excluding studies from any continent did not affect the pooled HR estimate for 
the association between exposure to PM2.5 and incidence of dementia with HR ranging 







Table 12. The Results of the Sensitivity Analysis (Leave-One-Out Analysis) for the 








Total I2  
Dementia     
All studies included 1.02 (1.01, 1.03) 95% 1.04 (1.02, 1.06) 100% 
Carey et al. (2018) (42) 1.01 (1.00, 1.03) 95% 1.04 (1.02, 1.06) 100% 
Chen et al. (2017) (46)  1.15 (1.06, 1.24) 96% 1.05 (1.03, 1.07) 99% 
Grande et al. (2020) (43)  1.01 (1.00, 1.01) 67% 1.03 (1.01, 1.05) 100% 
Ilango et al. (2020) (47)  1.02 (1.00, 1.03) 96% 1.04 (1.02, 1.07) 100% 
Oudin et al. (2018) (41)  1.02 (1.01, 1.03) 94% 1.04 (1.02, 1.06) 100% 
Smargiassi et al. (2020) (49) 1.15 (1.06, 1.24) 96% 1.05 (1.03, 1.07) 100% 
AD     
Jung et al. (2015) (39) - - 1.05 (1.03, 1.07) 100% 
NAD     
Yuchi et al. (2020) (48) - - 1.05 (1.02, 1.07) 100% 
First-time Hospitalisation     
All studies included 1.06 (1.01, 1.10) 99% 1.04 (1.02, 1.06) 100% 
Cerza et al. (2019) (51)  1.10 (1.00, 1.20) 94% 1.05 (1.03, 1.07) 100% 
Kioumourtzoglou et al. (2016) (50) 1.02 (0.97, 1.07) 100% 1.03 (1.01, 1.06) 100% 
Lee et al. (2019) (52)  1.07 (0.93, 1.23) 97% 1.01 (1.01, 1.02) 93% 
a Abbreviations: HR, hazard ratio, AD, Alzheimer’s disease; and NAD, non-Alzheimer dementia. 
 
3.8.2 Nitrogen Oxides 
The results of the sensitivity analysis for the association between exposure to NOX and the 
incidence of dementia is summarized in Table 13 (the model is presented in Fig. 6). 
Excluding neither of the studies could make the overall association of NOX and dementia 
statistically significant, although the pooled HR estimate ranged from 1.01 to 1.09 and Ι2 
ranged from 5% to 68%. When the study by Oudin et al. (65) was excluded, there was a 
statistically significant association between exposure to NOX and incidence of dementia in 
this subgroup (HR, 1.18; 95%CI, [1.04, 1.33]). In addition, the subgroup and the total 
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heterogeneities were reduced (subgroup’s Ι2, 8%; and total Ι2, 5%) when the study by 
Grande et al. (43) was excluded from the analysis.  
Table 13. The Results of the Sensitivity Analysis (Leave-One-Out Analysis) for the 








Dementia     
All studies included 1.09 (0.89, 1.70) 46% 1.04 (0.98, 1.10) 57% 
Andersson et al. (2018) (66) 1.08 (0.96, 1.22) 65% 1.03 (0.98, 1.09) 63% 
Grande et al. (2020) (43)  1.04 (0.96, 1.14) 8% 1.01 (0.99, 1.02) 5% 
Oudin et al. (2019) (65)  1.18 (1.04, 1.33) 0% 1.09 (0.95, 1.24) 68% 
First-time Hospitalization     
Cerza et al. (2019) (51)  - - 1.09 (0.98, 1.21) 46% 
a Abbreviations: HR, hazard ratio. 
 
3.8.3 Nitrogen Dioxide 
The results of the sensitivity analysis for the association between exposure to NO2 and the 
incidence of dementia is summarized in Table 14 (the model is presented in Fig 7). One-
by-one exclusion of the studies in the dementia subgroup did not change the total pooled 
HR (total HR range, 1.03 to 1.05; total Ι2 range, 78% to 96%); however, the pooled HR of 
the dementia subgroup remained significant only when the study by Smargiassi et al. (49) 
was excluded. In addition, only excluding the study by Cerza et al. (51) on the incidence 
of the first-time hospitalization with dementia increased the overall pooled HR and made 




Table 14. The Results of the Sensitivity Analysis (Leave-One-Out Analysis) for the 




Subgroup I2  
Total HR 
(95%CI) 
Total I2  
Dementia     
All studies included 1.07 (1.02, 1.12) 96% 1.04 (1.00, 1.08) 96% 
Carey et al. (2018) (42) 1.06 (1.00, 1.12) 97% 1.03 (0.99, 1.07) 96% 
Chen et al. (2017) (46)  1.08 (0.99, 1.19) 85% 1.03 (0.99, 1.07) 78% 
Ilango et al. (2020) (47)  1.05 (1.00, 1.11) 98% 1.03 (0.99, 1.07) 96% 
Smargiassi et al. (2020) (49) 1.9 (1.04, 1.14) 49% 1.05 (0.99, 1.12) 89% 
NAD     
Yuchi et al. (2020) (48) - - 1.04 (1.00, 1.09) 96% 
First-time Hospitalization     
Cerza et al. (2019) (51)  - - 1.06 (1.01, 1.10) 95% 
a Abbreviations: HR, hazard ratio; and NAD, non-Alzheimer dementia. 
 
3.8.4 Ozone 
Results of the sensitivity analysis for the association between exposure to O3 and the 
incidence of dementia is summarized in Table 15 (the model is presented in Fig 8). Leave-
one-out analysis of studies did not make the association between exposure to O3 and the 
incidence of dementia statistically significant. The pooled HR ranged from 0.85 to 1.04, 





Table 15. The Results of the Sensitivity Analysis (Leave-One-Out Analysis) for the 
Association Between Exposure to O3 and Incidence of Dementia a 
Excluded Study Total HR (95%CI) Total I2  
All studies included 1.01 (0.91,1.11) 82% 
Dementia   
Carey et al. (2018) (42) 1.03 (0.94, 1.13) 83% 
Chen et al. (2017) (46)  1.04 (0.93, 1.17) 69% 
AD   
Jung et al. (2015) (39) 0.85 (0.78, 1.10) 86% 
First-time Hospitalisation   
Cerza et al. (2019) (51)  0.96 (0.81, 1.15) 82% 
a Abbreviations: HR, hazard ratio; and AD, Alzheimer’s disease. 
 
3.9 Other Analyses 
Association between levels of pollutants was reported by some studies (Table 16). Since 
the confidence intervals were not provided, it was not possible to perform meta-analysis 
on the reported Pearson’s correlation coefficients. Reported estimates were heterogenous 
and association could not be implied from the reported values. Nonetheless, a positive 
association between PM2.5 and NO2 was reported by most of the studies while the 
association between PM2.5 and O3 ranged from -0.96 to 0.51 and the association between 


















Chen et al. (2017) (46)  0.38 b 0.38 b -0.22 b - - - 
Carey et al. (2018) (42) 0.98 -0.96 -0.99 - - - 
Cerza et al. (2019) (51)  0.66 -0.03 0.66 0.61 0.71 -0.12 
Jung et al. (2015) (39) - - 0.07b - - - 
Lee et al. (2019) (52)  -0.25 0.51 -0.59    
Smargiassi et al. (2020) (49) 0.75  - - - - 
Yuchi et al. (2020) (48)       
 AD 0.24 - - - - - 
 NAD 0.52 - - - - - 
a Abbreviations: AD, Alzheimer’s disease; and NAD, non-Alzheimer’s disease. 
b correlation coefficients for the baseline levels. 
 
While we intended to explore trends in the association between pollutants and dementia 
overtime, it was not possible to do so since it was not possible to separate those who were 
exposed before and after 2000 due to overlapping periods in the studies and the lack of 
patient-level data. In addition, meta-analysis based on sex was not feasible since sex was 
adjusted for in the original studies’ regression models.  
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Chapter 4  
4 Discussion 
Existing evidence from cohort studies suggests that PM2.5 is significantly associated with 
dementia. While other pollutants were not significantly associated with dementia, a 
clinically-relevant association could not be ruled out given the width of the confidence 
intervals. Meta-analysis showed that a 1μg/m3 increase in the level of PM2.5 is associated 
with a 4% increase in risk of any type of dementia, with varied duration of follow-up across 
the studies. In addition, the increased risk was higher for VaD (15%) in comparison to AD 
(4%). Although the pooled estimate showed a 4% increase in risk of any type of dementia 
per 10μg/m3 increase in NOX levels, the association was not statistically significant. There 
was a 7% increase in risk of dementia per 10μg/m3 increase in NO2 when only studies that 
reported incidence of dementia as the outcome were included; however, a 4% increase in 
risk of any type of dementia was not statistically significant when NAD and the incidence 
of the first-time hospitalization with dementia were included in the analysis. Finally, there 
was no association between the incidence of dementia and O3. The sensitivity analysis 
indicated that the pooled estimates were robust to exclusion of studies with small sample 
size. Nonetheless, there was a high heterogeneity of effects across all the studies and all 
the conducted analyses and leave-one-out analyses did not reduce the heterogeneity. The 
small number of studies made it difficult to assess for potential publication bias; however, 
visual inspection of funnel plots indicated that negative studies might have been missed 
while the tests for ruling out publication bias were underpowered due to a few available 
studies. Although studies that directly compared the highest to the lowest levels of 
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exposure could not be included in the meta-analyses, all of them individually reported a 
significant association between air pollution and dementia.  
While not the focus of this meta-analysis, additional studies indicated that there was no 
association between noise and dementia. Studies on the association of incidence of 
dementia and road proximity were contradictory, and in one study the association was not 
statistically significant when the model was adjusted for air pollutants (42). The presence 
of APOE ϵ4 strengthened the association between exposure to PM2.5 and incidence of 
dementia (40), but such an association was not seen with exposure to NOX (65).  
The strength of this study was in the inclusion of the most important air pollutants 
according to best available knowledge from existing studies. In the first search, we looked 
for the most important air pollutants to design our study. Then we searched more 
specifically for the more frequently investigated air pollutants. In addition, due to the small 
number of studies and recency of the issue, there were only two meta-analyses on the 
association of PM2.5 and incidence of dementia with few included studies, technical 
problems and no meta-analysis on the association of NOX, NO2, or O3 with the incidence 
of dementia. By including the latest studies published in 2020, this study is the first 
systematic review and meta-analysis to include all air pollutants. Moreover, in order to 
have a precise estimate, study authors were contacted, and new estimates based on the 
original data were used to calculate pooled estimates. 
This study has some limitations. Although air pollution has been associated with numerous 
health problems (14-17), the association of air pollutants with dementia has only recently 
attracted the attention of researchers, and therefore, there are few studies on this topic. In 
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addition, the effect of air pollution on neuronal cells might be evident only after long-term 
exposure, and given the nascent studies in the field, this makes drawing conclusions about 
causal associations difficult. Dementia is a condition of the elderly and numerous risk 
factors contribute to its pathology. Consequently, the incidence of dementia cannot be 
attributed to one cause, and our reported association should be treated conservatively.  
There was high heterogeneity across studies that maybe due to different study designs, 
sample sizes, diagnosis methods, measurement of air pollutants, and different geographical 
areas. Although the studies were population-based cohort studies, the recorded data and 
diagnostic criteria were not the same. Some studies included almost everyone in the 
registry and some studies used a proportion of the databases. Such studies are expensive, 
which limits the design and analysis to the available budgets. In addition to the extremely 
high price of accessing these databases, the access period to the data is limited. Once the 
authors had the data and finished working with it, it was difficult for them to provide more 
information, especially when the studies were conducted years ago. For this reason, a 
number of authors could not provide additional information when we contacted them.  
The levels of air pollutants were measured through different sources and various methods 
were used to assign the pollutants’ levels to residential addresses and estimate the exposure 
level in each individual. Most of the studies reported the mean annual level, which might 
not be an accurate measure of air pollutants where some days of the year might have had 
higher level of pollutants, for instance, school seasons. Moreover, climate may have 
changed over the different periods of observation contributing to the variability among 
studies. Another potential problem arises from land-use regression models. These models 
may misclassify exposure because the exposure is not evaluated at the individual level, and 
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depending on the number and distribution of the pollution measurement stations and 
available information about potential confounders, the classification may be biased. 
Furthermore, such a model does not consider daily or seasonal movements of individuals 
and that they might be exposed to different levels of exposure during the day due to 
working in a different place than their residential area. Furthermore, indoor pollution due 
to using wood or fossil fuel for cooking or heating is not considered in these models. People 
living in rural areas and on farms might be exposed to other types of pollutants that might 
have a detrimental effect on cognitive function and be associated with dementia. 
Furthermore, according to previous studies, the effect of pollution on cognitive function 
may begin during childhood (33, 34) and continues through adulthood (35-38). Therefore, 
where the population lived before enrolment in the study may be an important factor that 
was not considered in most of the studies. This could be especially relevant for countries 
with large populations of immigrants. 
At the analysis level, the exposure variables were not treated the same across studies. Some 
studies had dichotomized the exposure level, and some had divided the exposure level into 
tertiles or quartiles. In this case, it was not possible to provide pooled estimates, as they 
were not comparable. Even when the HR was provided for a certain unit increase in 
pollutant’s level, they were not easily compared because they used various increments such 
as IQR changes that varied depending on the total exposure levels in the studies. Although 
the units were converted to a specific unit increase, this conversion may introduce 
imprecision. In addition, upscaling the measurement units, for instance, conversion of one-
unit change to 10-unit change, might provide estimates that are beyond what the original 
data was intended to extrapolate. This was more evident when units of measurement were 
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converted from ppb to μg/m3 or vice versa. In addition, NOX is a mixture of NO2 and 
nitrogen monoxide and to convert the measurement units, the exact concentration of each 
molecule in the examined sample should be known. Therefore, the converted estimate 
might not be precise. 
In addition, the difference in adjustment for variables in the regression models posed 
challenges for our analysis. Although the studies had adjusted for risk factors of dementia, 
they did not adjust for the same variables, and this may impact on their reported estimates. 
Moreover, for most of the studies, the time between exposure and incidence of dementia 
was not clear. Even in studies that reported the mean exposure period before diagnosis of 
dementia, it was unclear when the pathology started and how long after the initiation of the 
molecular pathology dementia was diagnosed. While some evidence points to a strong 
association between CVD and dementia (79-81), and some evidence supports air pollution 
as a known risk factor for CVD morbidity and mortality (14), only one of the included 
studies evaluated the mediation role of CVD by providing three-year intervals for 
developing CVD before diagnosis of dementia (47). Although most of the studies had 
adjusted for CVD, they did not provide any information on the temporal association of air 
pollution with CVD incidence and dementia.  
The outcome definitions differed across the included studies. Some reported on the 
incidence of dementia and some focused on subtypes of dementia, i.e., AD, VaD, and 
NAD. In addition, three studies reported on the incidence of first-time hospitalization with 
dementia (50-52), where the non-hospitalized individuals with dementia were not included. 
Therefore, these studies were introduced to the analyses as subgroups and the analyses 
focused on the total incidence of dementia irrespective of the reported subtypes because 
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the clinical diagnosis of these subtypes does not necessarily confirm the involved 
neuropathology (5). Moreover, using registry data has its limitations as the codes and 
information are not complete which makes the certainty of the absence of dementia at 
baseline and the precise diagnosis of the outcome less reliable, which might lead to 
selection bias and misclassification of the outcome in included studies 
Most of the studies were performed in North America and Europe, where air quality 
regulation may be improved compared to other parts of the world. Low- and middle-
income countries in Africa, Asia, as well as South and Central America may face altered 
risks due to differing regulations, shorter life expectancy, and proximity of living 
conditions to roads and other areas where pollutants are generated. In addition, indoor 
pollution from cooking and heating and/or lighting are important additional contributors to 
exposure to pollutants in low-income countries (82-90). Interestingly, one included study 
in this meta-analysis indicated an association between PM2.5 from residential wood burning 
and incidence of dementia in Umea, Sweden. Although their results indicated a 55% 
increase in HR of dementia per 1μg/m3 increase in PM2.5 levels, the association was not 
statistically significant (41). Studies should be conducted in these areas to investigate the 
association of air pollution with dementia. In addition, future studies should implement the 
lessons from previous studies to design cohorts that not only include and adjust for 
important risk factors for dementia, but also consider the long-term effects of air pollution 
on health and the period between effect on the central nervous system and diagnosis of 
dementia. Given the interaction between and multitudes of exposure to each of these 
pollutants in combination, the association of air pollution with the incidence of dementia 
cannot be definitively attributed to increased levels of any one specific pollutant alone.  
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In addition, PM2.5 is defined based on the diameter of the particle and it can deliver 
numerous toxic ingredients as well as viruses and bacteria into the human body (22, 91). 
Therefore, it is difficult to assign the observed association to a particle that might have 
various ingredients potentially differing from region to region. Additional studies may 
provide better insight on the role PM2.5 plays on human health.  
Notwithstanding the limitations, our study has some implications for public health and 
government authorities, researchers, and the public.  
The world population is increasing, and advances in medical care and social wellbeing 
have improved life expectancy. This means that the elderly will constitute a large 
proportion of the population and therefore, conditions associated with ageing, such as 
dementia, will be more frequent. It is estimated that dementia cases will triple by 2050 
(11), and this may translateinto a ‘tsunami of dementia’ in the near future. Detecting and 
understanding preventable risk factors may help to mitigate this growth. One of the 
plausible and preventable contributors to dementia is air pollution. According to the 
“Ambient (outdoor) air quality and health” report by WHO in 2016, more than 90% of the 
world population is living in regions with higher than recommended levels of air pollution 
(21). Thus, if there is a causal association between air pollution and dementia, a large 
proportion of the population are at increased risk of developing dementia in the future. The 
sheer magnitude underscores the importance of further research to understand this 
association and effective mitigation efforts.  
While more studies are needed to evaluate the causal pathway between air pollution and 
dementia, current evidence points to a plausible association that is worthy of attention. 
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Since most of the pollution in the included studies concerned traffic-related air pollution, 
governments should improve regulations for air quality assessment and accelerate the 
transition from fossil fuels to sustainable energies such as electricity. In addition, public 
health authorities should consider programs to prevent dementia by reducing exposure to 
preventable risk factors for dementia including air pollutants. Such a plan mandates an 
interdisciplinary approach involving governmental, health, community, and funding 
sectors.  
These findings are also important to regular citizens. By understanding the imposed risk of 
dementia through exposure to air pollution, individuals would consider using sustainable 
energies, living away from regions with a high level of pollutants, and advocate for global 
interventions to reduce air pollution. 
The current study draws a scratch of a big picture that most of it are not completely 
understood yet. Further research is needed to improve our knowledge and understanding 
of the association between air pollution and dementia. Future prospective population-based 
studies should consider the limitations of previous studies such as measuring exposure 
more precisely with adequate follow-up over time to evaluate the effect of moving from 
one region to another. In addition, in countries with significant migration or immigration, 
the exposure before immigration should be considered. Dementia should be defined using 
standardized definitions, preferably with clinical assessment rather than by registry codes 
to prevent misclassification of the outcome. Moreover, prognostically relevant factors 
should be included in the analysis and if possible, the mediation role of other conditions 
such as CVD should be evaluated. In addition, the duration of exposure prior to developing 
dementia should be evaluated. Finally, sex should be included as a subgroup not just a 
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variable in the regression models so that difference between males and females can be 
evaluated. In conclusion, this meta-analysis of cohort studies indicates a significant 
association between exposure to PM2.5 and incidence of dementia. However, there were 
few studies on other pollutants, and the high heterogeneity of effects across studies should 
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Appendix A: Search Terms 










alzheimer* OR dementia) 
("air pollution"[MeSH Terms] "Particulate Matter"[ MeSH Terms] OR "Nitrogen Oxides"[ MeSH 
Terms] OR "Nitrogen Dioxide"[ MeSH Terms] OR "Nitrous Oxide"[ MeSH Terms] OR "Ozone"[ MeSH 
Terms] "Petroleum"[ MeSH Terms] OR "Sulfur Oxides"[ MeSH Terms] OR (air pollut*) OR 
(Particulate Matter*) OR (Nitrogen AND (Oxide* OR dioxide*)) OR (Nitrous AND Oxide*) OR 
(Ozone) OR (Sulfur AND Oxide*) OR smok* OR "Cooking"[Mesh] OR cooking* OR "environmental 
pollution"[MeSH Terms] OR "Environmental Pollutants"[Mesh Terms] OR "Environmental 
Exposure"[Mesh] OR "traffic-related pollution"[MeSH Terms] OR "Vehicle Emissions"[Mesh Terms] 
OR traffic-related OR traffic* OR car* OR Vehicle* OR road* OR transport* OR road-proximity OR 
"Fossil Fuels"[Mesh] OR "Petroleum Pollution"[Mesh] OR gas OR gasoline* OR diesel* OR fossil* 
OR petroleum* OR fuel* OR environment* OR "PM2.5" or PM10 or NOx OR NO2) AND (pollut* OR 














(TITLE-ABS-KEY ( particulate AND matter* ) OR TITLE-ABS-KEY ( nitrogen AND oxide* ) OR TITLE-
ABS-KEY ( nitrogen AND dioxide* ) OR TITLE-ABS-KEY ( nitrous AND oxide* ) OR TITLE-ABS-KEY ( 
ozone ) OR TITLE-ABS-KEY ( NO2 ) OR TITLE-ABS-KEY ( NOx ) OR TITLE-ABS-KEY (PM2.5) OR TITLE-
ABS-KEY ( smok* ) OR TITLE-ABS-KEY ( cooking ) OR TITLE-ABS-KEY (PM10) OR TITLE-ABS-KEY ( 
environment* ) OR TITLE-ABS-KEY ( traffic* ) OR TITLE-ABS-KEY ( car* ) OR TITLE-ABS-KEY ( vehicle* 
) OR TITLE-ABS-KEY ( transport* ) OR TITLE-ABS-KEY ( road AND proximity ) OR TITLE-ABS-KEY ( road 
) TITLE-ABS-KEY ( fuel* ) OR TITLE-ABS-KEY ( fossil* ) OR TITLE-ABS-KEY ( petroleum* ) OR TITLE-
ABS-KEY ( gas ) OR TITLE-ABS-KEY ( gasoline* ) OR TITLE-ABS-KEY ( diesel )) AND ( TITLE-ABS-KEY ( 










TS= (alzheimer* OR 
dementia)  
TS=(particulate AND matter*) OR TS=(nitrogen AND oxide*) OR TS=(nitrogen AND dioxide*) OR T
S=(NOx OR NO2 OR PM2.5 OR PM10 OR ozone OR O3 OR smoke* OR cooking OR environment* 
OR traffic* OR car* OR vehicle* OR transport OR road* ) OR TS=(road AND proximity) OR TS=(foss





























1. exp dementia/ or exp 
Alzheimer disease/ or 
alzheimer*.mp.  
2. exp semantic 
dementia/ or exp 
frontotemporal 
dementia/ or exp "mixed 
depression and 
dementia"/ or exp Pick 
presenile dementia/ or 
exp frontal variant 
frontotemporal 
dementia/ or exp senile 
dementia/ or exp 
multiinfarct dementia/ 
or exp dementia/ or exp 
Cornell Scale for 
Depression in Dementia/ 
or dementia.mp. or exp 
presenile dementia/ 
3. exp particulate matter/ or exp air pollution/ or air pollut*.mp. or exp air pollutant/ 
4. exp nitrogen dioxide/ or exp nitrogen oxide/ or nitrogen oxide*.mp. or exp ozone/ 
5. nitrogen dioxide*.mp.  
6. exp nitrous oxide/ or exp nitrous oxide emission/ or nitrous oxide*.mp.  
7. ozone*.mp.  
8. exp aerosol/ or exp airborne particle/ or particulate matter*.mp.  
9. exp pollutant/ or exp pollution/ or pollut*.mp.  
10. exp smoking/ or smok*.mp. or exp nicotine/  
11. environment*.mp.  
12. exp traffic/ or exp traffic related pollution/ or traffic-related pollut*.mp.  
13. exp motor vehicle/ or exp exhaust gas/ or vehicle emission*.mp.  
14. (road* or road proximity or vehicle* or car* or transport*).mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw, 
fx, dq, nm, kf, ox, px, rx, ui, sy, tc, id, tm, mh]  
15. exp petroleum derivative/ or petroleum*.mp. or exp petroleum/  
16. exp fossil fuel/ or fossil fuel*.mp.  
17. gasoline.mp. or exp gasoline/  
18. exp diesel fuel/ or exp diesel engine/ or diesel*.mp.  
19. exp fossil energy/ or fossil.mp.  
20. 3 or 4 or 5 or 6 or 7 or 8 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 
21. "PM10".mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq, nm, kf, ox, px, rx, an, ui, sy, tc, id, tm, mh]  
22. "PM2.5".mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq, nm, kf, ox, px, rx, an, ui, sy, tc, id, tm, mh]  
23. NO2.mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq, nm, kf, ox, px, rx, an, ui, sy, tc, id, tm, mh]  
24. NOx.mp. [mp=ti, ab, hw, tn, ot, dm, mf, dv, kw, fx, dq, nm, kf, ox, px, rx, an, ui, sy, tc, id, tm, mh] 
25. 20 or 21 or 22 or 23 or 24  
26. 1 and 2 and 25  
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